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ABSTRACT 
This study was conducted to test the hypothesis that enriching developing adipose tissue in 
long chain omega-3 long chain polyunsaturated fatty acids (n-3 LCPUFA) reduces adiposity 
compared to enrichment in n-6 LCUFA. Sixty Cobb 500 broiler breeders were fed a diet containing 
either 5% fish oil (FO) or corn oil (CO). After four weeks, fertilized eggs were collected and 
hatched, and all chicks were fed the same corn oil-based broiler starter diet. At days 7 and 14 post-
hatch, chicks in each group were weighed, euthanized and blood, liver, breast, and subcutaneous 
and abdominal fat samples harvested. Gas or liquid chromatography and mass spectrometry were 
used to determine the effects of diet on fatty acid profiles of tissue triglyceride, free fatty acid, 
phospholipid pools and protein expression. RNA sequencing and PCR was used to determine the 
effect on gene expression. Mixed model ANOVA and least square means were used to identify 
effects of maternal diet and age*diet interactions on chick phenotypes (SAS v9.4, Cary NC). 
Differentially expressed genes were determined using the DESeq2 R package. Hen dietary fat 
source did not significantly affect performance. Phospholipids and total lipids in muscle and 
adipose tissue of FO-chicks were significantly enriched in eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA) species relative to CO-chicks, with corresponding reductions in n-6 
LCPUFA (p<0.05). FO-chicks had significantly lower abdominal and subcutaneous fat deposition 
(p<0.05). Proteomics identified 95 known proteins that differed in abundance between FO and CO 
adipose tissue. KEGG pathway enrichment analysis of differentially abundant proteins indicated 
that hen FO feeding significantly suppressed glycolysis (n=5 proteins) and altered the cytoskeletal 
architecture of adipocytes and lipid droplet proteins (n=11 proteins). Hen FO resulted in 190 
upregulated and 46 downregulated genes 7 days and 13 upregulated and 32 down regulated genes 
at 14 days Combined, these results suggest that hen FO programs reduced adiposity by promoting 
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differentiation of adipocytes with reduced capacity for fatty acid uptake and storage. Future studies 
are needed to identify long term effects of this method of programming and additional strategies 
that may be necessary to sustain its effect. 
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CHAPTER I. 
LITERATURE REVIEW 
Excess fat accumulation in humans and animals 
Humans and other animal species store energy in the form of fat in order to maintain energy 
homeostasis. When energy intake is low, fat is mobilized and oxidized to provide the organs with 
energy. However, in some cases, the stored energy is not always utilized, thereby resulting in high 
accumulation of fat. If this excess energy is not utilized, over time, there are various negative 
consequences that can occur both in humans and in animals. In humans, the abnormal or excessive 
accumulation of fat, referred to as obesity, results in impaired health and an increased risk of 
metabolic and cardiovascular diseases (Buckley, et al., 2009; Chang, et al., 2015). Based on data 
collected in 106 countries, Kelly, et al., (2008) projected that the number of obese individuals are 
expected to increase and by the year 2030 there could be approximately 2.16 billion overweight 
and 1.2 billion obese individuals living in the world. Currently, in the United states, more than one 
third of adults and 17% of children are considered obese (Ogden, et al., 2014). If this trend 
continues there will be serious implications for public health and potentially an epidemic. Various 
factors have been implicated in the cause of obesity including genetics, high energy diets and low 
levels of physical activity (Rippe, et al., 1998). Combined, they make it very difficult to treat 
obesity hence more effort needs to be placed on prevention (Hill, et al., 1998). However, in order 
for prevention to be effective an understanding of the molecular mechanisms that regulate fat 
deposition and how they can be altered is necessary. Over the years, rodents have been the model 
utilized to gain insight into the mechanisms that result in fattening in mammals including humans. 
However, in recent years, chickens, particularly broilers (birds reared for meat) have been gaining 
more prominence as a model organism for obesity.  
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In chickens, excess fat accumulation is also a problem. In order to supply the growing 
demand for chicken and chicken products, poultry breeders selected and bred various breeds of 
chicken to develop strains of broilers that have increased growth and feed efficiency. However, 
one negative consequence of this selection of broilers for rapid growth is an increase in fat content 
of the marketable product (Griffin, et al., 1994) and an increase in fat accumulation in the abdomen 
(Fouad, et al., 2014). Though the fat deposited in the meat adds flavor and may influence 
consumers’ perception, abdominal fat deposition essentially wastes feed, increases processing 
costs and nitrogen waste, and is a negative trait to consumers who are conscious of their dietary 
fat intake (Ji, et al., 2012). In addition to broilers, excess fat is a concern in layers and broiler-
breeders because it impairs fertility and immune function (Siegel, et al., 2003). In addition, as with 
human obesity, excess fat may also impair skeletal muscle energy metabolism and compromise 
the efficient growth of lean tissue (Kelley, 2002). 
Broilers as a model for understanding excess fat deposition  
Through years of breeding and selection, broilers have been developed for rapid growth, 
and high feed efficiency. Being confined, they are not required to exert much energy to find food 
or participate in other natural activities. In addition to that, the diet they consume is high in energy. 
Similar to an obese human, most of the excess fat is stored in their abdomen. Some studies have 
shown that the molecular mechanisms regulating fat deposition in broilers and humans are very 
similar, making broilers a good model for understanding fatness in humans (Resnyk, et al., 2013). 
Also, like humans, the primary place of de novo lipogenesis is the liver, and very low density 
lipoprotein is responsible for the transport of fatty acids from the liver to the depots (Saadoun, et 
al., 1987). Therefore, taking advantage of these similarities, various research groups, including 
ours, have been utilizing broiler chickens as a model to better understand the mechanisms that 
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drive fat deposition and identify ways to regulate this process (Ji, et al., 2014). Though the 
development of chicks takes place outside of the hen, the chicken-egg relationship provides 
researchers with a model that allows for testing the direct impact of early exposure to certain 
nutrients. For example, by feeding hens diets enriched in various fatty acids, Koppenol, et al., 
(2015) established that fatty acids were taken up by the yolk and passed on to the offspring via the 
yolk sac. They concluded that, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) 
were incorporated into the yolk sac and transferred to the developing embryo. They also noted that 
at 28 d hepatic EPA and DHA concentrations were only affected in the perinatal period. Ji, et al., 
(2012) further highlighted the usefulness of chickens as a model by identifying pathways through 
which fat accumulation may be reduced by using genetic selection and management practices such 
as fasting. In an effort to understand the effect of the synthetic glucocorticoid dexamethasone on 
lipid metabolism, with broilers as a model, Cai, et al., (2009) reported that dexamethasone 
enhanced lipid metabolism. They were able to identify various genes involved in lipid synthesis, 
uptake and utilization that were significantly altered. By feeding diets that varied in the fatty acid 
profile, Crespo, et al., (2001) concluded that the fatty acid profile of various tissues was a direct 
reflection of  dietary fatty acid intake. In addition they concluded that diets containing 
polyunsaturated fatty acids decreased abdominal fat compared to saturated or monounsaturated 
fatty acids. Therefore, this relationship provides a unique model to study the role of nutrition in 
the maternal-fetal system because during development the embryo is in an isolated environment 
not under the influence of nutrients from maternal circulation as in the mammalian system 
(Cherian, 2008).  
4 
 
Developmental programming of obesity 
Developmental programming refers to the concept that changes in the environment within 
critical periods of development such as gestation or lactation has a permanent impact on 
metabolism and can result in the onset of certain diseases in adulthood. Since the period from 
conception to birth is a time of rapid growth, cellular differentiation and replication, exposure of 
the developing embryo to certain chemicals can have a long term impact on development 
(Simmons, 2008). Studies suggest that macronutrient intake influenced by maternal diet and body 
composition likely plays a role in the metabolic conditioning of the fetus in utero (Elshenawy, et 
al., 2016). These variations are based on epigenetic changes that alter the expression of various 
genes (Lisboa, et al., 2012). Different environmental stimuli which include diet, lifestyle habits 
(smoking, drinking) and other chemical exposures have been implicated in causing epigenetic 
changes. For example,  Veiga-Lopez, et al., (2016) reported that exposure to Bisphenol A (BPA) 
caused adipocyte hypertrophy in the visceral fat without an increase in the fat mass. These authors 
also concluded that exposure to BPA during fetal development at levels found in humans can 
increase the potential for insulin resistance. Similarly, Timmermans, et al., (2014) found that 
maternal smoking resulted in lower birth weight and greater body weight gain in the first year of 
life and increased body weight gain during infancy.  
Diet has also been shown to have a programming effect. Both diets low and high in various 
nutrients can have this impact. Saad, et al., (2016) reported that pups from dams fed a high fructose 
diet had a higher risk of obesity, hypertension, and metabolic dysfunctions. In sheep, maternal 
obesity increased fetal adiposity, fatty acid and glucose transporters, and expression of enzymes 
involved in fatty acid biosynthesis (Long, et al., 2012). According to Campbell, (2012), the 
inclusion of functional foods such as omega 3 fatty acids may be an approach to aid in the 
5 
 
management of obesity. In a recent study in humans, Vidakovic, et al., (2016) reported lower 
maternal n–3 PUFA concentrations and greater n–6 PUFA concentrations during pregnancy are 
associated with greater body fat and abdominal fat in childhood. Similarly, women consuming fish 
diets high in omega 3 polyunsaturated fatty acids at least three times per week had children with 
increased body mass index, growth, and adiposity in the first six years of life (Stratakis, et al., 
2016). 
Polyunsaturated fatty acids 
According to Madsen, et al., (2005), far more attention has been focused on strategies for 
treating obesity-associated diseases rather than focusing on preventing or treating the major 
underlying risk factor, obesity. They further stated that, understanding the processes that lead to 
de novo differentiation of adipocytes and onset of obesity would be necessary for developing new 
rational modalities for the prevention and treatment of obesity. Apart from their role as storage 
and transport forms of metabolic fuel, the fatty acid portion of dietary fats serves several other 
important functions in the body. These include providing for the essential fatty acid requirements, 
acting as structural components of cell membranes and serving as precursors for eicosanoid 
production (Fritsche, et al., 1993). Fatty acids are classified based on their length, location and 
number of double bonds they contain in relation to the methyl end of the fatty acid chain. These 
characteristics determine their specific activity and metabolic characteristics (Madsen, et al., 
2005). Saturated fatty acids contain no multiple bonds while unsaturated fatty acids contain one or 
more multiple bonds. Polyunsaturated fatty acids are classified as n-3 or n-6 based on the location 
of the first double bond from the methyl end of the carbon chain (Schmitz, et al., 2008). 
Research in both human and animal models has shown that n-3 fatty acids have distinct 
and important bioactive properties compared with other groups of fatty acids. In vitro studies with 
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adipocyte cell lines demonstrate that in comparison to their n-6 counterparts, n-3 fatty acids 
differentially regulate preadipocyte proliferation, adipogenesis, and triglyceride storage. Omega-
6 PUFAs, particularly arachidonic acid (AA; 20:4 n-6) tend to be pro-adipogenic (Gaillard, et al., 
1989; Massiera, et al., 2003; Negrel, et al., 1989), while LC n-3 PUFAs EPA (20:5 n-3) and (DHA; 
(22:6 n-3) attenuate lipid accumulation and promote an oxidative adipocyte phenotype 
(Fleckenstein-Elsen, et al., 2016; Kim, et al., 2006; Manickam, et al., 2010). In addition, n-3 fatty 
acids are known to reduce many risk factors associated with several diseases, such as 
cardiovascular diseases, diabetes, and cancer (Deckelbaum, et al., 2006).  
The simplest member of the omega-3 family, alpha-linolenic acid (18:3 n-3), can be 
converted to the more long chain n-3 PUFA and is considered to be the only dietary essential n-3 
PUFA. It can be converted into biologically active very long-chain n-3 PUFA, EPA and DHA 
through a series of desaturation and elongation reactions. However, this process is not very 
efficient therefore, EPA and DHA are normally required in the diet (Wojcik, et al., 2014). Long-
chain n-3 PUFA have a range of physiological roles that relate to optimal cell membrane structure 
and cell function and responses. Their longer chain length, high number of double bonds, and 
presence of the first double bonds enables them to generate different metabolites from other 
polyunsaturated fatty acids (Deckelbaum, et al., 2006).Thus, they may play key roles in preventing, 
and perhaps treating, many conditions of poor health and well-being. The multiple actions of n-3 
PUFA appear to involve multiple mechanisms that connect the cell membrane, the cytosol, and 
the nucleus. For some actions, n-3 PUFA appear to act via receptors or sensors, so regulating 
signaling processes that influence patterns of gene expression (Calder, 2012). 
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Epigenetic Regulation of gene expression  
DNA methylation is a class of epigenetic regulation in which a cytosine base is modified 
by DNA methyltransferase at the C5 position of cytosine. Approximately 70% of CpG (5’-cytosine 
phosphate-guanosine) dinucleotides in human DNA are constitutively methylated, whereas most 
of the unmethylated CpGs are located in CpG islands. CpG islands are CG-rich sequences located 
near coding sequences and they serve as promoters for their associated genes (Elshenawy, et al., 
2016; Hoile, et al., 2013). The methylation status of CpG islands within promoter sequences works 
as an essential regulatory element by modifying the binding affinity of transcription factors to 
DNA binding sites. In normal cells, most CpG islands remain unmethylated; however, under 
circumstances such as oxidative stress, they can become methylated de novo. Methylation is 
accompanied by changes in histone modification and chromatin structure, such that the CpG Island 
and its embedded promoter take on a repressed conformation that is incompatible with gene 
transcription (Elshenawy, et al., 2016). One critical gene involved in lipid metabolism that has 
been shown to be affected by methylation is the peroxisome proliferator activating receptor 
(PPAR) (Bagi, et al., 2004).  
Peroxisome proliferator activating receptors are transcription factors that regulate gene 
expression and so have a role in cell and tissue responses to the environment (Yoon, 2009). PPAR-
alpha (PPARα) and PPAR-gamma (PPARγ) are the most well understood PPAR isoforms. PPARα 
is expressed mainly in the liver. It is involved in regulating hepatic responses to the availability of 
certain fatty acids, fatty acid metabolites, and other peroxisome proliferators. PPAR-gamma is 
expressed in adipose tissue, where it regulates adipocyte differentiation and regulates the metabolic 
responses of adipocytes, including promoting insulin sensitivity. Two isoforms of PPARγ are 
formed by alternative splicing, of the two, PPARγ2 is predominantly found in adipocytes (Wu, et 
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al., 1999). During adipogenesis, PPARγ plays a critical role in the commitment of fibroblasts to 
become adipocytes in a ligand dependent way (Hihi, et al., 2002). Though other transcription 
factors may participate in adipogenesis, PPARγ is considered to be the only one necessary (White, 
et al., 2010). According to Rosen, et al., (2000) transcriptional regulators of adipogenesis such a 
PPAR tend to operate in a feed forward manner by inducing other pro-adipogenic factors and then 
working with those factors to increase gene expression.  
Firstly, they form a heterodimer with the retinoic-X-receptor (RXR) and upon binding 
interact with cofactors such that the transcription initiation is increased (Berger, et al., 2002; Wu, 
et al., 1999). This effect is elicited by the heterodimer binding to a short sequence of DNA, the 
PPAR response element in the promoter region of target genes (Bordoni, et al., 2006). Secondly, 
ligands binding to PPARs cause it to be activated and target various genes that play a role in 
adipogenesis, and lipid and glucose metabolism (Ryan, et al., 2011). Therefore, despite structural 
differences, PPARs are activated by noncovalent binding of ligands that include n-3 PUFA and 
various eicosanoid mediators (Calder, 2012) and serve as lipid sensors which when activated, 
significantly change metabolism (Evans, et al., 2004).   
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CHAPTER II. 
DIETARY FAT SOURCES, ADIPOSITY AND PRODUCTION TRAITS IN POULTRY 
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A version of this chapter is being prepared for publication as a review article by: Ronique 
C. Beckford, Robert I. Mihelic, Michael O. Smith, and Brynn H. Voy  
Abstract 
The primary goal of poultry producers is to meet the market demand for meat and eggs. 
While being efficient, poultry producers must ensure the production of a healthy, wholesome 
product that is beneficial to the consumers’ health. During diet formulation, fat is used to ensure 
that the birds’ energy requirement is met. However, dietary fatty acids also have a direct impact 
on the health of the birds, meat and egg quality, and fatty acid profile. Ultimately, consumers eating 
eggs and meat will be directly impacted by the fatty acids supplied by these products. In recent 
years, dietary fatty acids have been receiving much attention and various recommendations have 
been made about their daily intake in humans. Some fatty acids have been linked to various 
diseases and have been found to have adverse health effects. For example, consumption of diets 
that are low in omega-3 and high in omega-6 fatty acids have an increased risk of suffering from 
various illnesses such as obesity, cardiovascular diseases, and cancer in humans. Therefore, when 
considering the type of fat to include in the birds’ diet these factors should be taken into 
consideration. This review will highlight various types of fat that have been utilized in the diet of 
layers and broilers and the impact they have on performance, health status, fat deposition, product 
quality, as well as on consumer preference and health.  
Introduction 
The poultry industry is very dynamic and has responded to consumer demand in numerous 
ways. In an effort to adapt to consumer demands, adjustments have been made in management and 
production in the poultry industry. Consequently, in recent years there has been an increase in 
organic, no hormone added, no antibiotic ever, and cage free egg and meat production. Despite 
these changes, not much has been done in the area of meat and egg enrichment. Various studies 
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have shown that the diet consumed by broilers and layers has a direct impact on the fatty acid 
content of their products. Unlike in ruminants where ruminal microbes alter dietary fatty acids and 
change the fatty acids deposited in lean tissue, in poultry the fatty acid content of the meat and egg 
is a direct reflection of the diet (Woods, et al., 2009). Therefore, manipulating the chickens’ diet 
by adding feed ingredients that provide essential nutrients to consumers may be an avenue to 
improve the essential nutrient dietary intake. One such nutrient that is not consumed at the 
recommended amounts is omega-3 polyunsaturated fatty acid (n-3 PUFA). In particular, the long 
chain n-3 PUFA eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which have been 
proven to have numerous salubrious properties. However, with consumer awareness of the health 
benefits of these fatty acids increasing, there is a demand for enriching foods in with n- 3 fatty 
acids providing an opportunity for poultry producers to add value to their product (Zuidhof, et al., 
2009). 
Long chain n-3 fatty acids are considered dietary essential due to the low rate at which they 
are synthesized from precursors. In the human diet, fish has long been the source of EPA and 
DHA. However, over the past 100 years, there has been major changes in the type of fish consumed 
(Hulan, et al., 1988) and an increase in other protein sources that are high in n-6 fatty acids. High 
levels of n-6 fatty acids in the diets have been associated with a number of chronic diseases. 
Compared to n-6 fatty acids, n-3 fatty acids decreases the occurrence of cardiovascular related 
diseases (Calder, 2012) cancer, osteoporosis, and inflammatory autoimmune diseases (González-
Esquerra, et al., 2001; Simopoulos, 2006). Currently, the world health and American heart 
organization recommends the consumption of 200 to 500 mg of n-3 PUFA in the form of EPA and 
DHA 1 to 2 times per week for cardiovascular health (Campbell, 2012). However, daily intake 
especially in the western hemisphere fall  below the suggested amounts (Cherian, 2008b).  
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Adding fat to poultry diets is a common practice which is usually done to provide a dense 
energy source, control dust, improve diet palatability and provide essential fatty acids (Azain, 
2004). In addition, there is a strong relationship between dietary fatty acids and  the fatty acids of 
the end products of non-ruminants (Kouba, et al., 2011) which has been used to produce n-3 fatty 
acid enriched meat and eggs. In addition, studies have used it to directly alter the nutritional content 
of eggs to provide the developing embryo with essential fatty acids during development (Cherian, 
2008a). Other studies have reported a reduction in the n-6 to n-3 fatty acid ratio in the meat of 
broilers fed ingredients high in n-3 fatty acids (Hulan, et al., 1988; Rahimi, et al., 2011). 
Furthermore, studies have also reported that inclusion of n-3 fatty acids to the diet reduces the 
accumulation of abdominal fat and helps to alleviate the negative consequences of excess fat 
deposition.  
With poultry products being the number one source of protein in western diets and most 
countries around the world, enriching poultry products may be a viable option to increase the 
amount of n-3 fatty acids in the human diet. Over the years, various approaches have been taken 
to evaluate the differential effects of dietary fat types in poultry diet. Despite the number of studies 
conducted, no consensus has been reached for required levels of n-3 inclusion nor has a suitable 
inexpensive source been identified. In addition, inclusion of high levels of n-3 polyunsaturated 
fatty acids may have detrimental effects on immune function in chickens (Al-Khalifa, et al., 2012) 
bringing into consideration a welfare factor. If the poultry industry is going to utilize this approach 
to better serve consumers, it is important that the birds’ health is not compromised. Similarly, 
while there may be an advantage in enhancing the fatty acid profile of the meat, care must be taken 
to ensure that the sensory quality does not deteriorate (López-Ferrer, et al., 2001). According to 
González-Esquerra, et al., (2001) sensory quality of eggs and meat is decreased due to off flavors 
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and reduced lipid stability, which influences customer perception. Hence, the purpose of this 
review is to highlight the effect of utilizing n-3 fatty acids on bird performance, meat and egg 
quality, fat deposition and consumer preferences.  
Dietary fat types included in poultry diets 
In considering fat sources in broiler diets, cost and quality of the respective fats and impact 
on both animal performance and carcass quality have to be taken into account (Zollitsch, et al., 
1997). Due to the fact that animal-based fat such as tallow and grease were readily available and 
inexpensive, they became the primary source of fat utilized often at very high levels (Siedler, et 
al., 1955). Despite their benefits as an energy source, animal-based fats are high in saturated fatty 
acids which have been shown to have a negative impact on human health (Woods, et al., 2009). 
This criticism resulted in the increased use of less saturated fat sources. Currently, vegetable oil 
such as sunflower oil, canola oil, soybean oil, and corn oil are the most common fat sources used 
in the poultry diet (Allahyari-Bake, et al., 2017). The increased use of more plant based fat was a 
welcomed change as consumers were recognizing that the type of fat they consume was affecting 
their health. Though adjustments have been made in the type of fat utilized, the fatty acid content 
of the poultry diet is still much greater in saturated fats and unsaturated fatty acids of the n- 6 fatty 
acids class compared to n-3 fatty acids.  
Impact of dietary fat type on performance and bird health  
If changes are made to traditionally-fed poultry diets, the impact on growth and 
performance must be a focus since any reduction in productivity would be costly to producers 
(López-Ferrer, et al., 2001). Since differences in digestibility affect animal performance (Zollitsch, 
et al., 1997), it is imperative to optimize fat source and intake with poultry performance to meet 
consumer demands. Results from studies feeding titrated levels of long chain polyunsaturated fatty 
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acids are conflicting hence no consensus has been reached on suitable inclusion rates. Overall, 
regardless of the fat source, bird performance and health are not negatively affected (Sanz, et al., 
2000). In fact, lowering the levels of saturated and n-6 fatty acids in the diet may be more beneficial 
to the birds. Cortinas, et al., (2004) reported that performance of birds fed dietary polyunsaturated 
fatty acids was not altered; however, percentage thigh weight tended to increase as the level of 
unsaturation increased in the diet. Interestingly, Rahimi, et al., (2011) reported that feeding diets 
high in n-3 (flax seed and canola seed) had a negative effect on performance with birds having 
decreased body weight gain and greater feed conversion ratio despite having similar feed 
consumption. This difference however could be due to the fact that there may have been some 
anti-nutritional factors present in these oils as a result of the extraction process.  
One potential area that could benefit greatly from feeding diets high in n-3 fatty acids is 
abdominal fat deposition. One negative result of the selection for fast growing broilers has been 
an increase in depositing carcass fat. Most of the excess fat is not physiologically essential and is 
discarded during slaughtering and processing or before cooking (Chambers, et al., 1981). In order 
for this fat to be economically beneficial, the fat must be removed and reprocessed as a component 
of poultry by-product meal at a low cost (Hood, 1982). Therefore, identifying a way to reduce 
excess fat deposition would be beneficial to the broiler industry. Studies have shown that birds fed 
n-3 fatty acids have reduced subcutaneous and abdominal fat. Crespo, et al., (2002) reported that 
diets high in polyunsaturated fatty acids reduced fat content of abdominal and subcutaneous fat 
which accounts for approximately 30% of the total body fat. Similarly Sanz, et al., (2000) reported 
that feeding a saturated fat source then substituting it with an unsaturated source for the last eight 
days may reduce fat deposition and improve fat fluidity compared to using a saturated source 
throughout their entire life. Though adiposity was not decreased, Torchon, et al., (2017) found that 
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birds fed a diet containing fish oil from 7 to 30 days had significantly smaller adipocytes compared 
to those fed diets containing oils high in n-6 fatty acids.  
Earlier studies focused on the mechanisms that make n-6 fatty acids to be more pro-
inflammatory compared to the n-3. However, recent studies have also evaluated the effects of fatty 
acids on gene expression (Simopoulos, 2000) and their influence in regulating fat deposition. 
Utilizing molecular techniques and computer software, researchers have been able to better 
identify mechanisms that play critical roles in fat deposition. Ailhaud, et al., (2004) reported that 
key transcriptional regulators of various lipid related genes are affected by n-3 fatty acids. One 
potential benefit has been the ability of n-3 fatty acids found in fish oil in lowering serum 
triacylglycerol levels hence reducing fat accumulation in the adipocyte (Guo, et al., 2005). 
Influence of dietary fat type on fatty acid profile and quality of meat and egg  
Diet manipulation by incorporating different oils or oil seeds in poultry diet is the usual 
way of increasing the n-3 fatty acid content of poultry products. Currently, the egg industry has 
made more progress in producing and marketing enriched products (González-Esquerra, et al., 
2001). Omega-3 sources include plant and animal-based with the plant-based sources providing 
alpha linolenic acid while the marine sources provide eicosapentaenoic acid (EPA 20:5), 
docosapentaenoic acid (DPA, 22:5), and docosahexaenoic acid (DHA, 22:6) (Cherian, 2008a). 
According to López-Ferrer, et al., (2001) meat enriched in n-3 fatty acids, using all vegetable fat 
seems to be less effective compared to marine fat. Flax seeds or fish oil is commonly used to 
manipulate the n-3 fatty acid content of poultry foods. However, the efficiency of flax in increasing 
the content of long chain n-3 is limited after 10% inclusion in the bird’s diet (Cherian, 2008b). 
Adding flax results in an increase in α-linolenic acid (18:3) in triglycerides and long chain n-3 
fatty acids in the phospholipids (Cherian, 2008b). Similarly (Zuidhof, et al., 2009) found that 
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increasing the level or duration of feeding flaxseed decreased feed intake, body weight, and the 
carcass and breast yield. In a study comparing the feeding fish oil and sunflower oil (Newman, et 
al., 2002) found that, that birds fed fish oil had higher levels on n-3 in their phospholipid profile. 
On the other hand, birds fed sunflower oil, had higher levels of n-6 and had a fatty acid profile 
similar to birds fed tallow. Cortinas, et al., (2004) found that higher levels of polyunsaturated fatty 
acids in the diet resulted in higher accumulation in the thigh and breast. By feeding diets that varied 
in the level of polyunsaturated fatty acids, they were able to achieve EPA (2.05%) and DHA 
(0.99%) and EPA (3.17%) and DHA (2.79%) enrichment in the thigh and breast respectively. 
Influence of dietary fat source on consumer perception and health 
Long chain fatty acids, whether in adipose tissue or muscle, contribute to important aspects 
of meat quality and are central to the nutritional and sensory values of meat (Webb, et al., 2008). 
(Yang, et al., 2010) reported that fish oil tended to reduce ultimate pH of breast muscle. These 
authors also concluded that fish oil is liable to oxidization due to it being a rich source of long-
chain PUFA. Similarly, Betti, et al., (2009) reported that susceptibility to oxidation increased in 
both breast and thigh broiler meat with the duration of feeding flaxseed. In addition, these authors 
reported that enriching the diet for less than 16 d did not result in perceivable sensory defects. 
However, it was concluded that the duration of flaxseed feeding significantly affected the color 
characteristics, functional properties, and oxidative stability of broiler meat. 
Summary and conclusion 
Feeding diets high in n-3 polyunsaturated fatty acids to poultry to enrich meat and eggs 
could potentially be used as a means of improving the levels of n-3 fatty acids in the human diet. 
However if this method of enrichment is to be utilized, there are a number of factors that needs to 
be addressed. These include, identifying a suitable ingredient. The major source of long chain n-3 
polyunsaturated fatty acids is fish oil. However, feeding this to poultry may be very costly. Hence 
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identifying an ingredient that has a similar of better fatty acid profile would be critical. The suitable 
ingredient must also generate the same or better quality poultry products therefore it is important 
that all areas of production be taken into consideration. Similarly, consumer preference and 
willingness to purchase is essential. Also, factors that affect n-3 deposition before and after 
processing and during cooking must be identified.  
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Abstract 
Maternal intake of long chain n-3 polyunsaturated fatty acid (LC n-3 PUFA), particularly 
eicosapentaenoic acid (EPA; 20:5 n-3) and docosahexaenoic acid (DHA; 22:6 n-3) has been 
associated with reduced adiposity in offspring. We determined if enriching the developing embryo 
in LC n-3 PUFA influences adipose tissue development and metabolism. Chickens were used as a 
model because fatty acid content of the yolk, which supplies lipids to the developing embryo, can 
be manipulated through the hen diet. Cobb 500 hens (n=30/group) were fed broiler-breeder diets 
with fat (2.3 % fat wt:wt) from corn oil (CO; n-6) or fish oil (FO; n-3). After feeding hens for 28 
d, fertilized eggs were collected and hatched. All chicks were fed a CO-based (3 % fat wt:wt) 
broiler starter diet (n=28/group). Body and adipose weights (abdominal and subcutaneous) were 
measured at 7 and 14 d of age. Abdominal adipose tissue was used to measure adipocyte size, gene 
expression (QPCR), fatty acid composition (GC-MS), and proteomics (LC-MS/MS). Data were 
analyzed by ANOVA or t-test. Maternal FO significantly enriched chick adipose tissue in EPA 
and DHA and reduced adiposity (fat pad wt/body wt). At 14 d adiposity was reduced in abdominal 
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and subcutaneous depots by 38% and 40%, respectively in FO vs CO chicks (P<0.05). Adipose 
tissue of FO chicks was characterized by reduced adipocyte size, upregulated peroxisome 
proliferator activated receptor gamma (PPAR-γ) and PPAR-γ coactivator 1 beta (PPARGC1B) 
expression (each ~ 4-fold; P<0.001) and reduced expression of lipoprotein lipase (LPL) compared 
to CO chicks. Proteomics identified 95 differentially abundant proteins, including components of 
glucose metabolism and cytoskeletal organization. These results demonstrate that enriching tissues 
of the developing chick embryo in LC n-3 PUFA influences adipose development and reduces fat 
mass after birth. 
Keywords: Obesity, n-3 Polyunsaturated Fatty Acid, developmental programming, adipose 
tissue 
Introduction 
Active proliferation and differentiation of preadipocytes shortly before birth and in the first 
few years of life creates a sensitive window for adipose development (Baum, et al., 1986; Knittle, 
et al., 1979; Salans, et al., 1973). Consequently, the maternal diet and in utero environment can 
impact adipose deposition and the consequent risk for obesity. Adipose tissue is subject to 
developmental programming, in which dietary and environmental factors in utero exert lasting 
effects on tissue phenotypes. Variations in the maternal diet, lifestyle and environmental exposures 
have been linked to increased adiposity later in life through stable effects on adipocyte growth and 
metabolism (Bruce, et al., 2010; Lisboa, et al., 2012; Lukaszewski, et al., 2013). Programming of 
adipose tissue is of particular public health interest because obesity, which is epidemic in the U.S. 
and globally, begins early in life. Approximately 27% of children in the U.S. are overweight or 
obese by age five (Cunningham, et al., 2014). Obese children are much more likely to be obese as 
adults when compared to normal weight children (Freedman, et al., 2001; Guo, et al., 1999). 
Therefore, limiting excess fat accumulation in the first few years of life is an important tool for the 
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prevention of adult obesity. Evidence that adiposity at birth predicts fatness later in childhood 
highlights the need to understand prenatal factors that influence adipose development (Catalano, 
et al., 2009; Wang, et al., 2016).  
The types of fatty acids provided in the maternal diet may influence early adipose development 
and the resultant propensity for fat accumulation in children. In vitro studies with adipocyte cell 
lines demonstrate that polyunsaturated fatty acids (PUFAs) of the n-3 and n-6 series differentially 
regulate preadipocyte proliferation, adipogenesis, and triglyceride storage. Omega-6 PUFAs, 
particularly arachidonic acid (AA; 20:4 n-6) tend to be pro-adipogenic (Gaillard, et al., 1989; 
Massiera, et al., 2003; Negrel, et al., 1989), while LC n-3 PUFAs (e.g., eicosapentaenoic acid 
(EPA; 20:5 n-3) and docosahexaenoic acid (DHA; 22:6 n-3) attenuate lipid accumulation and 
promote an oxidative adipocyte phenotype (Fleckenstein-Elsen, et al., 2016; Kim, et al., 2006; 
Manickam, et al., 2010). Fatty acid profiles of diets in the US and other industrialized countries 
have shifted over the last several decades to favor consumption of n-6 PUFAs at the expense of n-
3 PUFAs (Blasbalg, et al., 2011). Both fatty acids supplied to the developing embryo and the fatty 
acid profiles of breast milk directly reflect the maternal diet (Arterburn, et al., 2006), creating the 
potential to impact the earliest stages of adipose development. Epidemiological attempts to 
associate maternal dietary fatty acid profiles with fat mass in children have been inconclusive. 
Two recent prospective studies demonstrated an inverse relationship between levels of n-3 PUFAs 
in maternal blood during pregnancy and fatness in childhood (Donahue, et al., 2011b; Vidakovic, 
et al., 2016). However, relative contributions of the pre- and perinatal maternal diet are difficult to 
separate from shared consumption patterns after lactation in human studies.  
 Avians provide a unique model in which to specifically manipulate the pool of fatty acids 
that are supplied to the embryo and test the effects on adipose deposition after hatch (i.e. birth). 
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The yolk provides the majority of fatty acids to developing tissues in the embryo, and for one to 
two days after hatch, until feeding is established. The fatty acid profile of the yolk can be modified 
through the source of dietary fat provided to the hen (Cherian, et al., 1996; Hargis, et al., 1991). 
For example, commercial eggs that are enriched in EPA and DHA are produced by supplementing 
the hen’s diet with marine oils. We used this relationship to test the hypothesis that enriching the 
embryo in EPA and DHA, supplied in fish oil, reduces adipose deposition in chicks. Corn oil was 
used as a reference because it contains a comparable level of PUFA (~ 60%), but primarily those 
of the n-6 family. All chicks were fed a corn oil-based diet after hatch to confine the experimental 
manipulation to the period of embryonic development. We demonstrate that maternal fish oil 
feeding significantly reduced adiposity after hatch, with no effect on growth. Our results suggest 
that fatty acids in the maternal diet contribute to developmental programming of adipose tissue. 
Materials and Methods 
Diets and husbandry 
Animal husbandry procedures were reviewed and approved by the Institutional Animal 
Care and Use Committees of the University of Georgia (broiler breeder hens) and the University 
of Tennessee (chicks). Cobb 500 broiler breeder hens maintained at the University of Georgia 
poultry unit were fed commercially-formulated broiler breeder diets in which fat (2% wt:wt) was 
provided from either fish oil (Menhaden) (FO) (Icelandirect; Clifton, NJ) or corn oil (Wesson), 
(CO) (Conagra Brands; Chicago IL) (n = 30 hens/diet). Diet composition is shown in Table 3.1. 
After 28 d, fertilized eggs were collected from each hen and transported to the University of 
Tennessee for incubation and hatching. Multiple roosters were used for fertilization of eggs in each 
diet group. Eggs were weighed and incubated for three weeks, until hatch. Hatch rates were 
calculated for each group as a percentage of eggs that produced viable chicks. At hatch, chicks 
were grouped by hen diet (CO or FO) and housed separately in brooder cages (n=10/cage) at 
31 
 
standard brooding temperature 35o C. Each cage was equipped with a feeder and drinker to which 
birds had ad libitum access. Both CO and FO chicks were fed a standard broiler starter diet in 
which fat (3% fat wt:wt) was supplied from CO. Weight gain and feed intake were monitored 
weekly.  
Blood and tissue collection  
Chicks were euthanized by CO2 asphyxiation. Two chicks from each group were 
euthanized at hatch for collection of liver and brain for lipid analyses. Samples of each tissue were 
snap-frozen and stored at -80o C. The remaining chicks were euthanized at 7 and 14 d of age. At 
the time of euthanasia blood was collected by cardiac venipuncture and transferred to 10 ml serum 
separator tubes (Fisher Scientific, Pittsburgh, PA). Serum was separated by centrifugation and 
stored at -80o C until analyses of circulating metabolites. Abdominal and femoral (subcutaneous) 
adipose depots were dissected and weighed as indices of adiposity. Samples of each depot and of 
liver were subsequently snap-frozen in liquid nitrogen and stored at -80oC. Samples of abdominal 
adipose tissue were fixed for 24 h at 4oC in paraformaldehyde (4%) for determination of adipocyte 
size by histology. 
Serum metabolites  
Commercially available colorimetric assay kits were used to measure serum glucose 
(Cayman Chemical, Ann Arbor, MI) and non-esterified fatty acid (NEFA) levels (Wako 
Chemicals, Neuss, Germany). 
Fatty acid analysis  
Abdominal fat samples from five randomly selected birds in each diet and age were 
analyzed for fatty acid composition by GC. Tissues (approximately 50mg) were pulverized under 
liquid nitrogen using a stainless steel mortar and pestle. Analyses were performed by the W.M. 
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Keck Metabolomics Research Laboratory (Iowa State University, Des Moines, IA). Data for each 
fatty acid were expressed as mole% ±SEM. 
Phospholipid analysis 
Fatty acid composition of phosphatidylcholine species in brain and liver collected at hatch 
(n=2/diet) and in abdominal adipose tissue collected at 7 d of age (n=5/diet) was analyzed using 
UPLC-MS. Tissue samples (100mg) were pulverized under liquid nitrogen using a mortar and 
pestle. Phospholipids were extracted using a modified Bligh and Dyer protocol (Milne, et al., 
2006).  Dried extracts were resuspended in 300PL of methanol/chloroform (9:1) for UPLC-MS 
analysis as described by (Campagna 2017).  
Lipids were identified with high resolution mass spectrometry using exact m/z and retention times. 
Lipid standards (Avanti Polar Lipids, Alabaster AL) from each phospholipid class were run to 
verify retention times. All ion fragmentation was used to confirm that phosphatidylcholines 
contained DHA and EPA as acyl chains. For all ion fragmentation scans, the resolution was 
140,000 with a scan range of 100-1500 m/z. The normalized collision energy was 30eV with a 
stepped collision energy of 50%. Lipids were identified by their fragments using Xcalibur software 
(Thermo Fisher Scientific, San Jose, CA). Data analysis was performed using Maven software 
(Clasquin, et al., 2012).  
Adipocyte size 
Abdominal fat samples from three birds/diet at each of the two ages were embedded, 
sectioned and stained with hematoxylin and eosin (two slides/bird) for determination of adipocyte 
size, as previously described by (Ji, et al., 2014). Briefly, images of three independent fields were 
captured on each slide under 20x magnification with the Advanced Microscopy Group EVOS XL 
Core microscope (Fisher Scientific, Pittsburgh, PA). For consistency, the same person performed 
33 
 
measurements. Image J (Version 1.48, National Institutes of Health) was used to determine 
adipocyte area, (μm2), using microscope settings of 2.8 μm/pixel, and using the restriction that 
measurements must exceed 500 μm2. Adipocytes were grouped into one of six arbitrary bins and 
the frequency of cells within each bin was determined. A standard method was used to calculate 
adipocyte number from adipocyte volume and adipose mass (Di Girolamo, et al., 1971).  
Real time PCR assay  
Total RNA was isolated from approximately 200 mg of abdominal adipose tissue and liver 
from five chicks in each treatment using InvitrogenTM TRIzolTM (Invitrogen, Carlsbad, CA). 
CDNA was synthesized from 500 ng total RNA in 20 μl reactions using iScript cDNA Synthesis 
kit (Bio-Rad Laboratories, Hercules, CA). Predesigned and validated primers for quantitative real-
time PCR (QPCR) were purchased from Qiagen (Quantitect; Germantown, MD). QPCR was 
performed in triplicate for each sample using iQ SYBR Green Master Mix (Bio-Rad Laboratories, 
Hercules, CA), as previously described (Ji, et al., 2014). Expression levels of genes of interest 
were normalized to expression of TBC1 domain family 8 used as a housekeeper. 
Proteomics 
Approximately one g of abdominal adipose tissue from each of three chicks per diet was 
pulverized in liquid nitrogen, of which approximately 60 mg was used for protein extraction. 
Proteins were extracted using a detergent-free, methanol/chloroform (2:1) protein extraction 
protocol (Vaisar, 2009) designed for lipid-rich tissues and based on the Bligh and Dyer method 
(Bligh, et al., 1959). Proteins were precipitated from the aqueous fraction using trichloroacetic 
acid and digested with sequencing grade trypsin. Approximately 2 mg of proteolytic peptides were 
obtained from each sample after clean up. Fifty μg aliquots of these peptides were used for 2D-
LC-MS/MS proteomic measurements on an LTQ Orbitrap mass spectrometer (Thermo Fisher), as 
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previously described (Li, et al., 2014). MyriMatch v2.1.111 (Tabb, et al., 2007) was used to search 
the raw mass spectra against the predicted protein database to identify fully-tryptic peptides, which 
were then grouped together into respective proteins with IDPicker v.3 (Ma, et al., 2009). Only 
protein identifications with at least two identified peptide spectra and a maximum q-value of 0.02 
were considered for further analysis. Peptide fragments were mapped to proteins in the Gallus 
gallus genome (V3.0) using Uniprot.  
Statistical Analysis 
The experimental design was a completely randomized design split plot with diets in the 
whole plots and age (d) in the subplots. Data collected at both 7 and 14 d (Weights, serum 
metabolites, tissue fatty acid composition, average adipocyte size and number) were analyzed 
using mixed model ANOVA with terms for diet, age and their interaction. Significant F-test (P < 
0.05) was followed by post-hoc testing using least square means to identify pairwise differences 
between groups. Adipocyte size frequency distributions within each age were further compared 
using t-test (P < 0.05) as were data collected at one age (QPCR, proteomics). Identified protein 
spectra counts were normalized and analyzed in MetaboAnalyst 3.0 (Xia, et al., 2015). Functional 
enrichment analysis was performed using the Database for Annotation, Visualization and 
Integrated Discovery (DAVID, V 6.8) (Huang, et al., 2008).  
Results 
Egg production and chick fatty acid composition 
Hatchability, egg weights, and chick weight at hatch were used to assess the effect of hen 
diet on egg quality, none of which differed significantly between eggs from CO and FO hens 
(P>0.05). The fatty acid composition of phospholipids contained in brain and liver was profiled to 
confirm that EPA and DHA were enriched in tissues of FO chicks, compared to CO chicks, at 
hatch. Brain and liver were used because of their relative mass at hatch. Enrichment levels of 
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phosphatidylcholine (PC) species containing EPA and DHA are shown in Table 3.2. The fold-
increase (FO/CO) ranged from ~ 1.2 (18:0/22:6 in brain) to ~ 130.4 (PC 18:4/22:6 in liver), with 
greater than 2-fold enrichment for most species. These data confirm that the maternal dietary fatty 
acid profile influenced was reflected in tissue fatty acid composition of the resultant chicks at the 
time of hatch. 
Gas chromatography-mass spectrometry (GC-MS) was used to quantify the effect of 
maternal fatty acid source on the fatty acid composition of developing adipose tissue. Fatty acid 
composition of the total lipid fraction of abdominal adipose tissue was analyzed at 7 and 14 d of 
age (Table 3.3). Tissue abundance of five fatty acids (palmitoleic, γ-linolenic, eicosenoic, 
eicosadienoic and docosanoic acids) increased with age (P<0.05) but was not affected by diet or 
age*diet interactions. Adipose tissue of FO chicks was significantly enriched in EPA and DHA at 
both ages (pDiet <0.01). At 7 d, tissue from FO chicks contained approximately six times more EPA 
than tissue from CO chicks. Enrichment declined from 7 to 14 d as all chicks consumed a corn oil-
based diet (pAge*Diet < 0.01), but still differed by ~ 2-fold. Comparable effects were seen for DHA 
content, which was increased by ~ 2.5-fold at 7 d and ~ 1.8-fold at 14 d (pDiet <0.01). As for EPA, 
the relative enrichment declined with age (pAge*Diet =0.03). Fatty acid composition of PC species 
in abdominal adipose tissue at 7d also reflected the maternal diet. Five species containing EPA or 
DHA were significantly increased, by 3- to 4-fold, in FO vs. CO tissue (Table 3.3). 
Body weight and adipose deposition 
Subcutaneous adipose tissue in chickens develops in the embryo and is visible at hatch, 
while the abdominal depot develops in the first few days after hatch. Weights of both depots were 
measured to assess the effect of FO in the maternal diet on offspring fat deposition. Body weights 
did not differ significantly between CO and FO chicks at 7d, but FO chicks were significantly 
36 
 
heavier than CO chicks at 14 d (Table 3.4). Maternal fatty acid source regulated adiposity of both 
depots in an age-specific manner. At 7 d, subcutaneous and abdominal adiposity did not differ 
significantly between FO and CO chicks (P>0.05). However, relative weights of both depots were 
significantly reduced in FO vs. CO chicks (P<0.05) at 14 d. On average, FO reduced adiposity by 
~ 38% in each of the two depots. Effects of maternal diet on adiposity were not associated with 
diet-induced differences in glycemia or lipolysis, as plasma glucose and NEFA levels were 
comparable between treatments at both ages (Table 3.4). The effects of maternal FO on abdominal 
adipose tissue were further explored because this is the depot in which broilers primarily deposit 
excess fat. Adipocyte size in H&E-stained sections of abdominal adipose tissue was measured to 
determine if fatness between groups differed due to hypertrophy. As expected, adipocyte size 
increased from 7 to 14 d, reflecting the rapid increase in fat deposition (Fig. 3.1). Average 
adipocyte size did not differ between FO and CO at 7 d (P = 0.21) but was significantly reduced 
in FO at 14 d (P = 0.03) Adipocyte number, calculated based on adipocyte size and adipose mass, 
showed a corresponding significant increase in FO vs. CO chicks at 14 (P=0.03) but not 7 d of age 
(P=0.12). Analysis of the adipocyte size distribution revealed that FO favored the abundance of 
small adipocytes, while there was a greater frequency of larger adipocytes in the CO chicks (Fig. 
3.1). At 7 d there was a significant increase in the percentage of adipocytes in the three larger bin 
sizes in the CO chicks (P < 0.05; Fig.3.1A). This effect persisted at 14 d with approximately a 3-
fold increase in the percentage of adipocytes (P = 0.02) in the largest bin (Fig. 3.1B). Conversely, 
approximately 66% of FO adipocytes were in the two smallest bins, compared to 49% in CO.  
Quantitative Polymerase Chain Reaction 
Potential mechanisms for the difference in adiposity were evaluated based on expression 
of genes that mediate fatty acid metabolism and adipogenesis. As shown in Fig. 3.3 A, adipose 
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tissue from FO chicks expressed significantly higher levels of peroxisome proliferator activated 
receptor-γ (PPARγ; 4.4-fold) and its coactivator PPARGC1B (PPARγ coactivator 1 β; 3.4-fold) 
than tissue from CO chicks (P<0.05). Conversely, expression of lipoprotein lipase (LPL) was 
approximately 60% lower in adipose tissue from FO vs. CO (P<0.05). Expression of carnitine 
palmitoyltransferase 1 (CPT1; mitochondrial fatty acid oxidation), acyl-coenzyme A oxidase 1 
(ACOX1; peroxisomal fatty acid oxidation), and fatty acid synthase (FASN; de novo lipogenesis) 
did not differ significantly between groups (Figure. 3.3 B; P>0.05). Liver is the primary site of de 
novo lipogenesis in avians (as in humans) (Leveille, et al., 1968) and plays an important role in fat 
deposition in broiler chickens (Leclercq, 1984). Diet did not significantly affect expression of 
CPT1, ACOX1 and FASN in liver (Figure 3.3 C), consistent with comparable hepatic triglyceride 
content in FO and CO chicks (data not shown). 
Adipose tissue proteomics 
The proteomes of adipose tissue from FO and CO chicks were compared to identify 
additional pathways that were altered by maternal FO feeding. A total of 95 known proteins 
differed significantly (P<0.05) between FO and CO chicks (Table 3.5). Functional enrichment 
analysis revealed that this set of proteins was enriched (adj. p-value <0.05) for components of 
cytoskeletal organization and cellular tight junctions, and for functions relevant to glycolysis and 
gluconeogenesis (Table 3.5). Proteins associated with the cytoskeleton (e.g., actin, vimentin, 
tubulin) were more abundant in FO vs. CO adipose tissue. Maternal FO also increased levels of 
the adipocyte lipid droplet protein perilipin (PLIN1) and Ras-related protein Rab-18 (RAB18; both 
~ 1.9-fold, FO/CO), although these changes did not meet the criterion for statistical significance 
(p=0.051 and 0.053, respectively). Glycolytic proteins were downregulated by maternal FO. 
Fructose-1, 6-bisphosphatase 1 and 2 (FBP1 and FBP2), pyruvate kinase (PK), enolase 3 (ENO3), 
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and phosphoenolpyruvate carboxykinase 2 (PCK2) were significantly less abundant in tissue of 
FO vs. CO chicks. Two fatty acid binding proteins, fatty acid binding protein1 (FABP1) and liver 
basic fatty acid binding protein (LBFABP), were also present at significantly lower levels in FO 
adipose tissue. Functional enrichment indicated that proteins involved in muscle development and 
filament structure differed between FO and CO chicks.  
Discussion 
This study fills a gap in knowledge by demonstrating that the types of fatty acids supplied 
to the developing embryo before birth influence adipose development. More specifically, enriching 
the maternal diet in FO reduced chick adiposity when compared to a maternal diet based on CO. 
All chicks were fed a CO-based diet after hatch, restricting the dietary manipulation to the period 
prior to hatch The feeding protocol that we used was developed to enrich eggs for the consumer 
market in DHA and EPA. Although we did not measure yolk fatty acids, we did find marked 
enrichment of EPA and DHA in liver and brain phospholipids at hatch, indicating diet enriched 
the developing embryo as expected. 
Attempts to retrospectively link fatty acid content of the maternal diet to child adiposity in 
humans have been inconclusive (Muhlhausler, et al., 2010). These types of studies are limited by 
reliance on BMI, which is a coarse index of adiposity in children, and on dietary recall to assess 
fatty acid intake. However, recent prospective studies using more sensitive measures of body 
composition and of fatty acid status have demonstrated an inverse relationship between maternal 
AA/DHA+EPA levels and childhood adiposity. A study of 227 mother-child pairs revealed that 
the ratio of AA/DHA+EPA in maternal circulation mid-pregnancy predicted adiposity in children 
at three years of age (Donahue, et al., 2011a). In a much larger study (4,830 mother-child pairs), 
Vidakovic, et al., (2016) reported that mid-pregnancy levels of EPA, DHA and docosapentaenoic 
acid (DPA) (22:5 n-3) pregnancy were associated with lower percentage of body fat and abdominal 
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fat in children at a median age of six years. Likewise, maternal levels of n-6 PUFA were associated 
with increased childhood adiposity. The ratio of AA/DHA+EPA in transitional breast milk, which 
reflect dietary patterns in the previous 90 days, was also recently shown to predict body fat 
percentage at four months of age (Rudolph, et al., 2016). Interestingly, none of these studies found 
a significant relationship with body weight or BMI, just as we found no effect of maternal FO 
feeding on chick body weight or growth, suggesting specific effects on adipose tissue. Each of 
these studies profiled fatty acids in the maternal blood, which provides a sensitive assessment of 
intake during pregnancy. However those levels may not completely reflect fatty acid delivery to 
the embryo, which also depends upon transfer across the placenta (Hornstra, 2000). They also may 
be confounded by the child’s dietary intake after birth and lactation, particularly those that 
measured adiposity a few years after birth. Our findings complement these studies by 
demonstrating that fatty acids provided during embryonic development alone are sufficient to alter 
adiposity.  
The shift towards increased small adipocytes coupled with upregulation of PPAR-γ and its 
coactivator PGC-1β suggest that maternal FO promoted adipogenesis, despite reducing adiposity. 
EPA and DHA can act as ligands to activate PPAR-γ, which would be expected to promote 
adipogenesis through this nuclear receptor’s role in orchestrating adipocyte differentiation. 
However, in vitro studies have shown both pro-and anti-adipogenic effects of EPA and DHA, 
which may be due to variation in cell lines, differentiation protocols, reference treatments, and 
fatty acid concentrations (Chambrier, et al., 2002; Murali, et al., 2014; Oster, et al., 2010). 
Interestingly, a shift towards increased frequency of small adipocytes and increased expression of 
PPAR-γ has been described in fat-1 mice, which endogenously synthesize n-3 PUFA due to 
transgenic expression of a novel fatty acid desaturase from C. elegans (White, et al., 2015). 
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Microarray data indicated that constitutive synthesis of n-3 PUFAs within adipocytes of fat-1 mice 
markedly suppressed expression of GATA3, which normally inhibits the progression of 
preadipocytes into differentiation by directly suppressing PPAR-γ (Tong, et al., 2000).  
Reduced availability of glycerol-3-phosphate and fatty acids for triacylglycerol synthesis 
may have restricted hypertrophy of FO adipocytes. Esterification of fatty acids into triacylglycerol 
requires a steady supply of glycerol-3-phosphate. In adipose tissue, this is synthesized during 
glycolytic metabolism of glucose, and from pyruvate through glyceroneogenesis (Chaves, et al., 
2006; Forest, et al., 2003). Levels of several glycolytic proteins and of PEPCK, which is rate-
limiting for glyceroneogenesis, were reduced in FO vs. CO adipose tissue. In chickens (and 
humans) the majority of stored fatty acids are delivered to adipose tissue from the liver. 
Lipoprotein lipase, which cleaves fatty acids from circulating lipoproteins, was also down-
regulated in FO adipose tissue. In combination, these effects suggest that maternal FO may have 
reduced adipocyte size, at least in part, by attenuating the capacity to extract, esterify and store 
fatty acids as triacylglycerol. Whether this is a primary effect of maternal FO or a secondary 
response to reduced delivery of fatty acids from liver cannot be determined, as we did not measure 
plasma VLDL levels. However, hepatic lipogenesis (based on expression of FASN) and 
triglyceride content (data not shown) did not differ between FO and CO, suggesting that diet did 
not alter the supply of fatty acids from liver.  
A growing body of literature illustrates that the structural assembly of lipid droplets 
influences lipid metabolism in adipocytes. Maternal FO feeding increased the abundances of three 
proteins, PLIN1, VIM and RAB18, which localize to the surface of adipocyte lipid droplets and 
play key roles in balancing lipid storage and mobilization. Perilipin1 is the major surface protein 
of adipocyte lipid droplets, where it orchestrates lipolysis by controlling access of lipase enzymes 
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to triacylglycerol molecules (Blanchette-Mackie, et al., 1995a; Blanchette-Mackie, et al., 1995b; 
Londos, et al., 1996). Vimentin is an intermediate filament that scaffolds lipid droplets to maintain 
their individual structural integrity (Schweitzer, et al., 1998). Rab18 facilitates exchange of lipids 
between lipid droplets and the endoplasmic reticulum, playing roles in both lipolysis and 
lipogenesis (Martin, et al., 2005; Ozeki, et al., 2005). All three proteins are critical for the physical 
remodeling and trafficking that are necessary for storage and mobilization of lipids. The 
physiological significance of increased levels of vimentin, perilipin1 and Rab18 in FO adipose 
tissue requires further study, but the roles of each protein and their interactions in lipid mobilization 
suggests that this response may facilitate lipid utilization within adipocytes. Consistent with this 
possibility, overexpression of perilipin was shown to induce fatty acid oxidation in white 
adipocytes (Sawada, et al., 2010). Follow-on studies are prompted to determine how maternal FO 
influences adipocyte architecture and if this contributes to the reduction in adiposity.  
The mechanisms through which maternal consumption of LC n-3 PUFA can reduce 
adiposity in offspring remain to be determined. Transcriptional control through PPARs by EPA, 
DHA and their metabolites would require sustained enrichment of those fatty acids within adipose 
tissue. Fatty acid profiling demonstrated that the total lipid pool of FO chicks was enriched in both 
EPA and DHA up to 14 d, although the fold-enrichment relative to the CO group decreased 
between weeks one and two. How long this enrichment persists, especially when the post-hatch 
diet is not supplemented with FO, remains to be determined. Epigenetic modifications of genes 
involved in adipose deposition may also underlie reduced adiposity in FO chicks. In a recent 
randomized, controlled clinical study, fish oil supplementation during pregnancy was shown to 
differentially methylate 21 chromosomal regions at birth, with some differences persisting to five 
years of age (van Dijk, et al., 2016). Circulating DHA levels, both early in pregnancy and at birth, 
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were significantly correlated with methylation of PPAR-α in infants (Marchlewicz, et al., 2016), 
indicating the potential for epigenetic programming of lipid metabolism. Follow-on studies to 
characterize methylation patterns and other epigenomic marks of maternal FO feeding are needed 
to explore this possibility. 
Chickens provide a unique means to address maternal programming by dietary fatty acids, 
but several caveats and limitations should be noted. Fish oil and CO were the sole sources of 
dietary fatty acids in our model. This was intentional, to maximize enrichment of the yolk in EPA 
and DHA. However, fatty acid consumption in human diets is more diverse and complex, and the 
level of enrichment we achieved may not occur in the context of a typical human diet. 
Nevertheless, our results provide proof-of-principle that fatty acids provided prior to birth regulate 
adipose development. As such, they contribute additional rationale for further studies in humans 
to determine if maternal fatty acid intake can be used to reduce the risk of childhood obesity. Intake 
of most fish species during pregnancy is now encouraged by the US Food and Drug 
Administration, easing previous concerns about safety of fish oil intake through foods (2017). Our 
study was also limited to measuring adiposity within a short period (up to 14 days) after hatch, so 
the longevity of reduced fatness is unknown. Recent studies linking maternal levels of EPA and 
DHA during pregnancy with child fatness at up to six years of age encourage the interpretation 
that the programming effects of FO may persist. It should also be noted that chicks in the FO group 
were significantly heavier at 14 (but not 7) days of age, despite having significantly less adipose 
tissue. We infer that this difference in weight was due to differences in breast muscle, which grows 
at its fastest rate in this age span and accounts for 10-15% of body weight (Scheuermann, et al., 
2003). However we did not weigh muscle in this study. Further studies are necessary to evaluate 
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differences in lean growth in our model, and the potential effects of maternal FO on development 
of other tissues.  
In summary, our data demonstrate that maternal fish oil consumption reduces adipose 
deposition in offspring. Our study was limited to the first two weeks of life, and follow-on 
experiments are necessary to determine how long this effect persists as chicks mature. These 
results complement recent studies in humans that link LC n-3 PUFA in the maternal diet to reduced 
adipose mass in children. Accordingly, they highlight the potential to attenuate fat accumulation 
and potentially the risk for childhood obesity through dietary intervention prior to birth.  
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Appendix 
Table 3.1. Composition of FO and CO broiler breeder diets fed to hens for 28 d 
Ingredients Amount, % 
   FO                               CO 
Corn 63.16 63.16 
Soybean meal (48 %) 11.85 11.85 
Wheat midds 8.00 8.00 
Limestone 7.90 7.90 
Pro-pak1 5.00 5.00 
Fish oil 2.30 - 
Corn Oil - 2.30 
Mono calcium phosphate 0.60 0.60 
Termin-82 0.30 0.30 
Salt 0.20 0.20 
Vit Pre-mix3 0.20 0.20 
Bicarbonate of Soda 0.15 0.15 
DL-Methionine 0.14 0.14 
Choline 0.12 0.12 
TM Pre-mix4 0.08 0.08 
Calculated nutrient analysis   
ME, kcal/kg 2938 2938 
CP, % 15.20 15.20 
Calcium, % 3.5 3.5 
Total phosphorus 0.61 0.61 
Available phosphorus 0.43 0.43 
1FO, fish oil; CO, corn oil  
1Protein concentrate, H.J. Baker and Bros., 595 Summer Street, Stamford, CT 
06901-1407 2Antimicrobial preservative 
3Vitamin mix provided per kilogram of complete diet: vitamin A, 30,800 IU; 
Vitamin D3, 9,250 IU; vitamin E, 153.9 IU; vitamin B12, 0.154 mg; riboflavin, 46.2 mg; 
niacin, 185 mg; pantothenic acid, 84 mg; menadione sodium bisulfite, 16.2 mg; folic 
acid, 12.3 mg; pyridoxine HCl, 46.2 mg; thiamine HCl, 20.5 mg; biotin, 9.3 mg; choline, 
2,944 mg; niacin, 185 mg 
 4Mineral mix provided per kilogram of complete diet: Cu, 55 mg; I, 7.3 mg; Fe, 
366 mg; Mn, 310 mg; Zn, 321 mg; K, 2.23 g; Mg, 1.09 g; Se, 0.48 mg 
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Table 3.2. Enrichment of brain and liver phospholipids at hatch in broiler chicks produced from 
hens fed diets containing FO or CO for 28 d 
 FO/CO ratio 
PC species Brain Liver 
PC(38:10) 7.40 130 
PC(36:5) 13.9 13.9 
PC(34:5) 21.5 11.1 
PC(42:11) 11.4 6.62 
PC(34:6) 4.98 4.79 
PC(38:8) 6.29 4.76 
PC(44:12) 1.65 4.01 
PC(40:6) 1.19 2.51 
PC(38:7) 2.16 2.43 
PC(36:6) 1.85 2.09 
PC(40:9) 2.41 1.71 
FO, fish oil; CO, corn oil N=2/group  
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Table 3.3. Abdominal adipose tissue fatty acid content of broiler chicks produced from hens fed 
diets containing FO or CO for 28 d 
Diet CO FO  Effect 
Age 7 d 14 d 7 d 14 d SEM Diet Age Diet x Age 
Fatty Acid % of total  P-value 
Capric (C10:0) 0.007 0.007 0.005 0.009 0.001 0.28 0.45 0.28 
Lauric (C12:0) 0.024 0.020 0.024 0.027 0.002 0.13 0.81 0.13 
Myristic (C14:0) 0.520 0.462 0.555 0.577 0.031 0.06 0.70 0.21 
Myristoleic (C14:1) 0.144 0.154 0.152 0.195 0.015 0.13 0.11 0.31 
Pentadecanoic 
(C15:0) 
0.058 0.056 0.060 0.054 0.007 0.10 0.61 0.77 
Palmitic (16:0) 22.43 22.13 23.42 28.86 1.920 0.61 0.20 0.15 
Palmitoleic (C16:1) 5.170 6.090 5.610 7.94 0.610 0.08 0.01 0.27 
Heptadecanoic(C17:0
) 
0.096 0.081 0.095 0.085 0.006 0.94 0.33 0.83 
Stearic (C18:0) 5.723 5.032 5.430 6.381 0.509 0.49 0.87 0.29 
Oleic (C18:1) 30.67 30.02 31.22 18.15 4.36 0.21 0.14 0.17 
Linoleic (C18:2n6c) 16.45 17.16 15.93 17.979 1.378 0.99 0.39 0.55 
Linoleladic (18:2n6t) 16.45 16.81 15.60 17.613 1.781 0.99 0.39 0.55 
G-Linolenic (18:3n6) 0.180 0.206 0.164 0.209 0.015 0.68 0.03 0.55 
Alpha linolenic 
(18:3n3) 
0.718 0.672 0.689 0.722 0.067 0.88 0.92 0.56 
Arachidic (20:0) 0.052 0.056 0.052 0.071 0.006 0.26 0.11 0.30 
Eicosenoic (C20:1n9) 0.289 0.367 0.280 0.439 0.027 0.27 <0.01 0.16 
Eicosadienoic 
(C20:2) 
0.134 0.155 0.137 0.169 0.010 0.45 0.03 0.60 
Eicosatrienoic 
(C20:3n3)  
0.131 0.142 0.143 0.166 0.001 0.12 0.15 0.60 
Eicostrienoate 0.205 0.189 0.145 0.145 0.001 0.07 0.78 0.77 
Eicosapentaenoic 
(C20:5n3) 
0.009b 0.010b 0.060a 0.02a 0.005 <0.01 <0.01 <0.01 
Erucic (C22:1n9) 0.015 0.013 0.014 0.016 0.001 0.29 1.00 0.20 
Docosanoic (C22:2) 0.031 0.037 0.031 0.043 0.003 0.29 <0.01 0.36 
Tricosanoic (C23:0) 0.050 0.035 0.030 0.029 0.006 0.045 0.20 0.25 
Docosahexaenoic 
acid (C22:6n3) 
0.036b 0.016b 0.092a 0.028b 0.007 <0.01 <0.01 0.03 
Nervonic (C24:1n9) 0.017 0.006 0.008 0.008 0.004 0.39 0.17 0.20 
Activity index1         
SCD-16 0.226 0.286 0.240 0.282 0.028 0.85 0.08 0.75 
SCD-18 5.412 7.474 5.902 3.680 1.316 0.23 0.95 0.12 
D6D 0.006 0.01 0.004 0.010 0.002 0.57 0.01 0.57 
DNL 0.683 0.646 0.753 0.084 0.132 0.11 0.91 0.50 
EL 0.260 0.220 0.232 0.216 0.019 0.40 0.15 0.53 
FO, fish oil; CO, corn oil; N= 5/diet/age; Effect (diet, age, and diet X age) P-value from 
ANOVA; Labeled means in a row without a common letter differ; p<0.05. 1Indices of 
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enzyme activities calculated from mol%, using the following equations: SCD (Stearoyl-
CoA desaturase)-16 (16:1n-7/16:0); SCD-18 (18:1n-9/18:0); D6D (Delta-6 desaturase) 
(18:3n-6/18:2n-6); DNL (De novo lipogenesis) (16:0/18:2n-6); EL (Elongation) (18:0/16)  
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Table 3.4. Effect of dietary enrichment on performance and serum metabolites of broiler chicks 
produced from hens fed diets containing FO or CO for 28 d 
                      Diet CO FO  Effect 
                      Age  7 d 14 d 7 d 14 d SEM Diet Age Diet x 
Age 
      P-value 
Hatch body wt (g) 41.6 41.6 40.6 38.5  1.04 0.05 0.31 0.33 
Final body wt (g) 123b 241a 111b 303a 26.7 0.35 0.001 0.18 
Glucose (mg/dL) 276 303 346 314 92.3 0.29 0.56 0.20 
NEFA (mM) 0.57 0.65 0.61 0.64 0.27 0.85 0.49 0.80 
Abdominal adiposity (%) 0.34c 1.21a 0.31c  0.75b 0.11 0.04 0.001 0.06 
Subcutaneous adiposity (%) 0.91ab 1.23a  0.85b 0.74b 0.8 0.02 0.38 0.08 
FO, fish oil; CO, corn oil; N= 10/diet/age; Effect (diet, age, and diet X age) P-
value from ANOVA; Labeled means in a row without a common letter differ; p<0.05. 
Adiposity=depot weight/body weight x100  
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Table 3.5. Differentially expressed proteins in abdominal adipose tissue of FO vs. CO chicks at 14 
d 
 
 
FO/CO 
ratio P-value2 
Protein 
symbol Protein name 
Increased 
(FO/CO) 4.20 0.017 EPB41L1 erythrocyte membrane protein band 4.1-like 1 
 3.49 0.002 VIM Vimentin 
 3.24 0.023 HBAA hemoglobin alpha, subunit A 
 3.04 0.000 TBA1 tubulin alpha-1 chain 
 3.01 0.024 ANK1 ankyrin 1, erythrocytic 
 2.97 0.034 NFASC Neurofascin 
 2.71 0.001 DST Dystonin 
 2.69 0.001 FMO3 
dimethylaniline monooxygenase [N-oxide-
forming] 
 2.69 0.000 ACTG1 actin, gamma 1 
 2.65 0.000 ACTB actin, beta 
 2.64 0.001 TBB7 tubulin beta-7 chain 
 2.63 0.000 ACT5 actin, cytoplasmic type 5 
 2.62 0.042 COL28A1 collagen, type XXVIII, alpha 1 
 2.55 0.022 SPTB spectrin, beta, erythrocytic 
 2.55 0.001 ALB Albumin 
 2.49 0.011 A2ML2 alpha-2-macroglobulin-like 2  
 2.44 0.012 ITIH2 inter-alpha-trypsin inhibitor heavy chain 2 
 2.40 0.046 IGF2R insulin like growth factor 2 receptor 
 2.29 0.028 BDH1 3-hydroxybutyrate dehydrogenase, type 1 
 2.16 0.035 FBLN1 fibulin 1 
 2.12 0.008 TUBA3 tubulin alpha-3 chain-like 
 2.01 0.042 PELO pelota homolog  
 2.00 0.051 PLIN1* perilipin 1 
 1.98 0.054 RAB18* ras-related protein Rab-18 
 1.88 0.017 RBP4 retinol-binding protein 4 
 1.85 0.017 ANXA5 annexin A5 
 1.83 0.003 TMED7 
transmembrane emp24 protein transport 
domain containing 7 
 1.79 0.003 TF transferrin  
 1.78 0.054 VDAC3 voltage dependent anion channel 3 
 1.70 0.024 TUBAL3 tubulin alpha like 3 
 1.69 0.002 TUBB4B tubulin beta 4B class IVb 
 1.69 0.007 TUBA3E tubulin alpha 3e 
 1.65 0.010 TUBA4B tubulin alpha 4b 
 1.63 0.024 PLA2G6 phospholipase A2 group VI 
 1.61 0.034 NSF 
N-ethylmaleimide sensitive factor, vesicle 
fusing ATPase 
 1.57 0.032 ERAP1 endoplasmic reticulum aminopeptidase 1 
 1.54 0.034 DNM1L dynamin 1 like 
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Table 3.5. continued 
 
 
FO/CO 
ratio P-value2 
Protein 
symbol Protein name 
 1.53 0.003 TBB3 tubulin beta-3 chain 
 1.52 0.007 USP9X ubiquitin specific peptidase 9, X-linked 
 1.50 0.043 PIT54 PIT54 protein 
Decreased     
(FO/CO) 0.56 0.020 TXN Thioredoxin 
 0.51 0.046 HMGCL 3-hydroxymethyl-3-methylglutaryl-CoA lyase 
 0.45 0.019 PKM pyruvate kinase, muscle 
 0.44 0.031 TNX avian tenascin X 
 0.41 0.045 LAMA5 laminin, alpha 5 
 0.38 0.024 PPA2 pyrophosphatase  
 0.33 0.008 FXR1 
fragile X mental retardation, autosomal 
homolog 1 
 0.33 0.034 GIF gastric intrinsic factor 
 0.31 0.033 NT5C2 5'-nucleotidase, cytosolic II 
 0.31 0.033 NT5C3 cytosolic purine 5'-nucleotidase 
 0.31 0.014 FBP1 fructose-1,6-bisphosphatase 1 
 0.28 0.050 UQCRFS1 
ubiquinol-cytochrome c reductase, Rieske 
iron-sulfur polypeptide 1 
 0.25 0.039 LBFABP liver basic fatty acid binding protein 
 0.22 0.032 ATP2A3 ATPase, Ca++ transporting, ubiquitous 
 0.21 0.008 MYH1G myosin, heavy chain 1G, skeletal muscle  
 0.20 0.009 CKM creatine kinase, muscle 
 0.20 0.009 MYH1C myosin, heavy chain 1C, skeletal muscle  
 0.20 0.006 MYL1 myosin, light chain 1, alkali; skeletal, fast 
 0.19 0.021 PCK2 phosphoenolpyruvate carboxykinase 2  
 0.18 0.004 MYH1B myosin, heavy chain 1B, skeletal muscle  
 0.17 0.003 MYH1F myosin, heavy chain 1F, skeletal muscle  
 0.17 0.020 MYL3 
myosin, light chain 3, alkali; ventricular, 
skeletal, slow 
 0.17 0.006 CRYAB crystallin, alpha B 
 0.17 0.005 MYSS myosin heavy chain, skeletal muscle 
 0.15 0.005 MYH1E myosin, heavy chain 1E, skeletal muscle  
 0.15 0.003 MYH1D myosin, heavy chain 1D, skeletal muscle  
0.15 0.021 PDLIM5 PDZ and LIM domain 5 
 0.15 0.004 ENO3 enolase 3  
 0.15 0.002 MYLPF 
myosin light chain, phosphorylatable, fast 
skeletal muscle 
0.15 0.013 AK1 adenylate kinase 1 
0.15 0.002 MYH1A myosin, heavy chain 1A, skeletal muscle  
0.14 0.007 DMD Dystrophin 
 0.13 0.002 LAMA2 laminin, alpha 2 
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Table 3.5. continued 
 
 
FO/CO 
ratio P-value2 
Protein 
symbol Protein name 
 0.13 0.003 GATM glycine amidinotransferase 
 0.13 0.002 FABP1 fatty acid binding protein 1 
 0.12 0.000 ANKRD2 ankyrin repeat domain 2  
 0.11 0.003 MYH13 myosin, heavy chain 13, skeletal muscle 
 0.11 0.004 MYH15 myosin, heavy chain 15 
 0.10 0.000 MYL2 myosin, light chain 2, regulatory, cardiac, slow 
 0.10 0.003 MYSC myosin heavy chain, cardiac muscle isoform 
 0.10 0.000 ADPRHL1 ADP-ribosylhydrolase like 1 
 0.10 0.007 MYOZ2 myozenin 2 
 0.10 0.000 FBP2 fructose-1,6-bisphosphatase 2 
 0.09 0.027 SRCA sarcalumenin 
 0.09 0.002 XIRP1 xin actin-binding repeat containing 1 
 0.09 0.002 ATP2A1 
ATPase, Ca++ transporting, cardiac muscle, 
fast twitch 1 
 0.08 0.000 TMOD4 tropomodulin 4  
 0.08 0.022 TNNI2 troponin I type 2  
 0.08 0.001 AMPD1 adenosine monophosphate deaminase 1 
 0.06 0.052 MYOM1 myomesin 1 
 0.06 0.020 APOBEC2 
apolipoprotein B mRNA editing enzyme, 
catalytic polypeptide-like 2 
 0.05 0.010 CAMSAP1 
calmodulin regulated spectrin associated 
protein 1 
 0.04 0.003 TNNT3 troponin T type 3  
 0.04 0.004 CASQ2 calsequestrin 2  
 0.04 0.009 MYOZ1 myozenin 1 
FO/CO ratio is the ratio of normalized protein abundance in abdominal adipose 
tissue at 14 d from N=3 samples per diet group; CO, corn oil; FO, fish oil. P-values are 
from T-tests, FO vs. CO 
* included to show trend because of potential biological relevance 
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Table 3.6. Functional enrichment of differentially abundant proteins in adipose tissue of chicks 
produced from hens fed diets containing FO or CO for 28 d 
GO Enrichment    
ID Term Count Adj. P-value 
GO:0007010 cytoskeleton organization 11 1.16 x 10-6 
GO:0030049 muscle filament sliding 7 3.85 x 10-6 
GO:0006094 gluconeogenesis 5 3.49 x 10-3 
GO:0007517 muscle organ development 6 3.31 x 10-3 
GO:0007017 microtubule-based process 4 3.26 x 10-2 
GO:0006928 movement of cell or 
subcellular component 
5 3.26 x 10-2 
KEGG Pathway    
ID Pathway Count Adj. P-value 
04530 Tight junction 7 0.0052 
00010 Glycolysis/gluconeogenesis 5 0.0297 
FO, fish oil; CO, corn oil; N=6/diet/age; Adj. P-value = P-value adjusted for false 
discovery using Bonferroni correction. 
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Figure 3.1. Adipocyte volume and number in CO and FO chicks at 7 and 14 d of age. 
Representative H&E-stained images of abdominal adipose tissue from CO (A, B) and FO (C, D) 
used to determine adipocyte volume at 7 (A, C) and 14 (B, D) d. Scale bar = 40 μm. Two slides 
and three independent fields/slide were counted in three chicks in each age/diet group. (E), average 
adipocyte volume (μm3 X 104), ± SD; (F) average adipocyte number (X 106),± SD; * = P<0.05, 
FO vs. CO, post-hoc comparison using LSM 
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Figure 3.2 Frequency distribution of adipocyte area (μm2) of CO and FO chicks at 7 (A) and 14 
(B) d of age. Adipocyte areas measured from H&E-stained images were divided into arbitrary 
bins; average frequency of cells within each bin, ± SEM; * = P < 0.05; # = P < 0.10, FO vs. CO. 
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Figure 3.3. Expression of genes involved in adipogenesis, fatty acid oxidation and uptake of fatty 
acids in adipose tissue (A, B) and liver (C) of CO and FO at two weeks of age.ACOX1, Acyl-CoA 
oxidase 1; CPT1, Carnitine palmitoyltransferase 1; PPARG, Peroxisome proliferator-activated 
receptor gamma; PPARGC1B, Peroxisome proliferator-activated receptor gamma co-activator 1 
Beta; FASN, Fatty acid synthase; LPL, Lipoprotein lipase; average relative abundance, ± SEM;* 
= P < 0.05, FO vs. CO; n=5-6/diet group. 
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CHAPTER IV. 
TRANSCRIPTIONAL ANALYSIS OF ABDOMINAL FAT OF BROILER   CHICKS 
PROGRAMMED TOWARDS REDUCED FAT DEPOSITION  
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manuscript and is the corresponding author. 
Abstract  
Adipose tissue is subject to maternal programing, in which the maternal diet or 
environment before birth influences adipose accumulation in offspring. Dietary long chain n-3 
polyunsaturated fatty acids (LC n-3 PUFA) have been shown to reduce adipose mass in broiler 
chickens when fed during the period of rapid growth between hatch and market age. We recently 
demonstrated that providing LC n-3 PUFA in the hen diet reduced adiposity in chicks compared 
to a diet enriched in n-6 PUFA, suggesting the potential to program reduced adiposity in chicks 
through the type of fat provided to the hen. The objective of this study was to identify potential 
mechanisms for LC n-3 PUFA programming of adipose deposition. Abdominal adipose tissue of 
chicks that hatched from hens fed fish oil (LC n-3 PUFA) or corn oil (n-6 PUFA) was profiled by 
RNA sequencing (RNAseq). Cobb 500 broiler chicks were hatched from broiler breeder hens fed 
diets containing fat (5%) from either fish oil (FO) or corn oil (CO) for 4 weeks. Post hatch, chicks 
were fed a CO-based diet after hatch, until 7 or 14 days of age. The type of fat provided in the hen 
diet significantly affected chick adipose transcriptomes at both 7d and 14 d. At 7 d 190 genes were 
upregulated while 46 genes were downregulated in FO vs. CO chicks. The influence of hen diet 
persisted at 14 d, although fewer genes (45) were significantly affected. Hen FO feeding was 
associated with differential expression of genes involved in mesenchymal stem cell differentiation 
and muscle development at 7d, as well as a number of genes involved in lipid and glucose 
metabolism. Although fewer genes were affected by diet at 14 d, effects on lipid metabolism and 
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other aspects of cell development were apparent. A total of eight genes were differentially 
expressed at both ages, indicating that part of the influence of diet is sustained after hatch. In 
conclusion, these data suggest several candidate pathways that may contribute to programming of 
adipose development through maternal dietary fat. 
Introduction 
Two major goals of the poultry industry are to increase carcass yield and reduce the amount 
of fat deposited in the abdomen (Fouad, et al., 2014). However, broilers selected for their fast 
growth and efficient feed conversion inadvertently deposit fat in their abdomen (Griffin, et al., 
1992). Ultimately, excess fat deposition wastes feed, reduces feed efficiency, and increases 
processing cost. Hence reducing is the amount of fat accumulated here would be economically 
beneficial to producers. The abdominal fat depot differs from other depots in both size and time of 
development. Unlike the neck and subcutaneous depot, abdominal fat develops significantly after 
hatch (Butterwith, 1997). Also, the growth of the abdominal fat pad occurs through both 
hyperplasia and hypertrophy until the chicks are approximately two weeks of age, after which 
hypertrophy is responsible for its expansion (Butterwith, 1997; Hood, 1982). Since there are two 
distinct time points and mechanisms by which abdominal fat accumulates, multiple opportunities 
to target excess fat deposition are possible.  
Various studies have shown that dietary manipulations may be a way to reduce excess fat 
deposition in broilers. One such manipulation that has been utilized is altering the different fatty 
acids included in the diet. Fatty acids, particularly long chain n-3 polyunsaturated fatty acids (LC 
n-3 PUFA) have been found to reduce excess fat deposition in rodents, humans, and chickens. 
According to Azain, (2004) fatty acids and their derivatives may have hormone-like effects and 
have been be shown to regulate gene expression in preadipocytes, which ultimately effects their 
proliferation and differentiation. However few studies have evaluated the impact of providing 
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these nutrients during development. Developmental programming refers to the concept that, early 
exposure of the developing embryo to certain stimuli influences growth and development. This 
impact can have detrimental consequences not only on the offspring but also future generations 
(Elshenawy, et al., 2016). Studies in humans have shown that children exposed to chemicals such 
as bisphenol A (Veiga-Lopez, et al., 2016), air pollutants (Lavigne, et al., 2016),  or cigarette 
smoke (Timmermans, et al., 2014) before birth may express physiological changes during 
development.  
In the current study we capitalized on the relationship between the diet a chicken consumes 
and the impact it has on the egg. Unlike in ruminants, fatty acids found in the diet are not altered 
during digestion. Therefore, the fatty acid content of the egg is a direct reflection of the hen diet. 
Hence, the developing embryo will have access to these fatty acids which will directly influence 
their development. Utilizing this model, we previously demonstrated that early exposure of the 
developing embryo to the LC n-3 PUFA eicosapentaenoic acid (EPA) and docosahexaenoic acid 
(DHA) attenuated adipose mass after hatch without impacting growth. Chicks hatched from hens 
that were fed a diet enriched in fish oil (FO; 5%) had reduced adipose weight, with smaller 
adipocytes, than those hatched from hens fed equal amounts of fat as corn oil (CO). All chicks 
consumed a CO-based diet after hatch, suggesting that reduced adiposity resulted from 
developmental programming through hen dietary fat source. Proteomic analysis of adipose tissue 
from 14d chicks indicated that gluconeogenesis and adipocyte cytoskeleton were influenced by 
the hen diet.  Understanding the mechanisms through which maternal dietary fat quality regulates 
offspring adipose development has important potential applications for both the poultry industry 
and for human health. Therefore in the present study we utilized RNA sequencing to compare the 
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adipose transcriptomes of chicks that were hatched from hens fed FO or CO to identify potential 
mechanisms through which dietary fat programs offspring adipose development. 
Materials and Methods 
Tissue collection and RNA extraction  
Detailed animal husbandry procedures can be found in (Beckford, et al., 2017). At 
dissection, abdominal adipose tissue samples were snap-frozen in liquid nitrogen and stored at –
80oC. Total RNA used for sequencing was isolated from abdominal adipose tissue of five chicks 
in each treatment group using TRIzolTM (Invitrogen, Carlsbad, CA). Frozen abdominal adipose 
tissue was first pulverized under liquid nitrogen to produce a homogeneous powdered sample, 
from which approximately 200 mg were removed for RNA isolation. Quality and quantity of 
extracted RNA samples were measured using the Experion (Bio-Rad (Hercules, CA)) automated 
electrophoresis system. RNA quality indicator (RQI) values of samples ranged from 7.4 to 9.8.  
RNA sequencing  
RNA sequencing was conducted by Novogene (Chula Vista, CA) using the Illumina HiSeq 
4000 sequencing platform (Illumina, San Diego, CA). After independent verification of RNA 
quality, cDNA libraries were created from each RNA sample (5/diet/age; n=20) using NEBNext 
Ultra RNA Library kit according to procedures developed by the manufacturer (Illumina). After 
library construction, the insert size of each library was determined using a 2100 Bioanalyzer 
(Agilent, Santa Clara, CA). QPCR was used to quantify effective concentration (> 2 nM) of each 
library prior to sequencing. A minimum of 20 M PE 150 bp reads were obtained from each library. 
Quality of sequencing from each library was evaluated using fastQC before proceeding with 
statistical analyses http://www.bioinformatics.babraham.ac.uk/projects/fastqc/.  
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Trimming and mapping  
The reference genome for the chicken (Gallus gallus, build 5.0) in FASTA format and the 
corresponding annotation file in GTF format were obtained from Ensembl 
(ftp.ensembl.org/pub/release–90). This version of the chicken genome consists of 18,346 genes, 
represented by 38,118 transcripts. Prior to mapping, reads were trimmed using skewer with default 
parameters (Jiang, et al., 2014) to remove adapters. Reads were mapped to the chicken genome 
using STAR 2.4.0.1 (Dobin, et al., 2013). The generated BAM alignment files were then converted 
to SAM files using SAM tools and a table of read counts was generated using HTSeq-count 
(http://www-huber.embl.de/users/anders/HTSeq/doc/overview.html) for analysis of differential 
expression. 
Differential gene expression 
The R statistical computing package (v. 3. 4. 2), DESeq2 (v 1.16.1) was used to identify 
genes that were differentially expressed in FO vs. CO chick adipose tissue. DESeq2 uses as input 
a matrix of un-normalized read counts, which are internally corrected for variation in library size. 
Pre-filtering was performed by excluding transcripts with fewer than 10 total reads across the 10 
samples (5 FO and 5 CO) in each age group. Statistically significant effects of diet on gene 
expression in each of the two age groups were identified using t-test, using p-values adjusted for 
FDR (α = 0.05). The Database for Annotation, Visualization and Integrated Discovery (DAVID), 
v 6.8, was used to functionally annotate differentially expressed genes based on Gene Ontology 
(GO) annotation and KEGG pathway enrichment (Huang, et al., 2008). 
Results  
RNA sequencing was used to characterize the abdominal adipose tissue gene expression of 
broiler chicks hatched from hens fed either a diet containing CO or FO for four weeks. A total of 
20 – 56 million reads were produced for each sample. Approximately 70% of reads were mapped 
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to the genome, representing ~ 18,000 genes (Table 4.1). The extent to which abdominal gene 
expression profiles could discriminate chicks based on maternal diet was evaluated using 
unsupervised clustering. As shown in Fig. 4.1, chicks separated into their treatment groups, based 
on expression of the 50 most variable genes between samples. These results illustrate the relative 
effects of the maternal diet on chick adipose transcriptomes. Comparison of FO and CO at each of 
the two ages indicated that maternal dietary fat source significantly affected abdominal adipose 
tissue gene expression post-hatch. A total of 236 genes differed significantly (adj. p-value ≤ 0.05) 
between the two groups at 7 d .Of these, 136 transcripts are annotated to known or putative genes 
in the ENSEMBL database, based on the current assembly (Gallus_gallus-5.0) of the chicken 
genome. A total of 190 genes were upregulated, and 36 downregulated in FO relative to CO chicks 
(Table 4.2) (Table 4.3). Functional analysis based on GO annotation revealed that FO increased 
the expression of a set of genes (~ 23) that are assigned functions related to muscle cell 
differentiation and development. In addition, expression of several genes related to lipid and 
glucose metabolism (e.g., fatty acid binding protein 1 (FABP1), liver basic fatty acid binding 
protein (LBFABP), fructose-1,6-bisphosphatase 2 (FBP2), protein kinase, AMP-activated, alpha 
2 catalytic subunit (PRKAA2) were upregulated in FO vs. CO adipose tissue at this age. The set 
of 36 genes that were downregulated in FO vs. CO included glucagon (GCG), glucagon receptor-
like protein (LOC772096), insulin like growth factor 2 receptor (IGF2R) and other genes with 
various functional annotations. Effects of the maternal diet on chick adipose transcriptomes 
persisted at 14 d, although the number of genes that differed significantly between the two groups 
(45) was lower than at 7 d. A total of 32 genes were upregulated (Table 4.4) and 13 downregulated 
(Table 4.5), in FO vs. CO at this age. Effects of diet on lipid metabolism were reflected in persistent 
upregulation of FABP1, and by down-regulation of stearoyl-CoA desaturase 5, in FO vs. CO 
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adipose tissue. Eight genes (two of which are unannotated) were significantly affected by diet at 
both ages.  
Discussion 
Diet is the most easily manipulated component of poultry production, and the intuitive 
choice for strategies to reduce fat deposition. However, modifying the diet can be costly. Even 
modest increases to the cost of a ration can have significant impact because feed is the primary 
cost of production, and broilers eat ad libitum. Further, diet modifications cannot compromise 
growth. Adipose tissue is known to be influenced by developmental programming, through which 
the diet and lifestyle of the mother alter the accumulation of adipose tissue in offspring. In humans, 
the relationship between maternal diet and lifestyle and child adipose tissue can persist years after 
birth, into adulthood. With respect to poultry production, this potential for programming of adipose 
tissue creates the possibility to exert sustained impact on fat accretion by altering the maternal diet 
while still feeding a standard ration in chicks after hatch. We recently demonstrated that feeding 
hens a diet enriched in FO reduces adipose mass and alters adipocyte development in chicks, 
compared to a diet enrich in CO. Understanding the potential mechanisms for this response has 
broad utility for poultry and other species, and provided the rational for transcriptomic analyses 
described herein.  
A number of genes with functions relevant to adiposity were differentially expressed 
between FO and CO chicks at 7d. Two intracellular fatty acid binding proteins (fatty acid binding 
protein 1 (FABP1) and liver basic fatty acid binding protein (LBFABP)) were upregulated in FO 
chick adipose tissue. Fatty acid binding protein 1 is involved in lipid uptake, and its expression is 
induced during proliferation of adipocytes, as differentiation is initiated (Samulin, et al., 2008). 
The function of LBFABP is not been well-characterized, although it was shown to be differentially 
expressed in liver of genetically lean vs. fat chickens (Zhang, et al., 2013). No orthologs have been 
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described in mouse or human, suggesting that it may be a novel avian fatty acid binding protein. 
Potential effects of maternal diet on lipid handling are also reflected by expression of α/β hydrolase 
fold domain 3 (ABHD3), which was downregulated in FO vs. CO tissue. This gene is one of a 
family of lipid metabolizing proteins that has been suggested to play an important signaling role 
in the control of energy balance (Lord, et al., 2013). Expression of ABHD3 is regulated by PPARγ, 
which is considered as the master transcriptional regulator of adipogenesis (Soccio, et al., 2015). 
At least three genes that differed between FO and CO at 7 d regulate signaling activity through 
AMPK and protein kinase A (PKA), both of which influence lipid metabolism in adipocytes. 
Adenosine monophosphate deaminase 1 (AMPD1) controls the phosphorylation status of AMPK 
(Tandelilin, et al., 2015), a subunit of which is encoded by protein kinase, AMP-activated, alpha 
2 catalytic subunit (PRKAA2). Both were expressed at significantly higher levels in FO chick 
adipose tissue. 
One possible mechanism through which hen dietary fish oil altered chick adipose gene 
expression after hatch is through epigenetic modification. Methylation status of several of the 
genes affected by maternal diet at 7d has been associated with adiposity in other species. The 
purinergic receptor P2RY1 regulates leptin production in white adipocyte (Laplante, et al., 2010)s, 
and its methylation level correlates with body mass index in humans (Ramos-Lopez, et al., 2018). 
Methylation of phosphoglycerate dehydrogenase (PHGDH), which is involved in serine 
biosynthesis, has also been associated with BMI and with abdominal adiposity in large-scale 
human studies (Aslibekyan, et al., 2015). The maternal diet has been shown to specifically alter 
expression levels and methylation of insulin-like growth factor receptor 2 (IGFR2), PRKAA2, and 
ankyrin repeat domain 1 (ANKRD1) in fetal adipose tissue. have been shown to be differentially 
methylated in fetal adipose tissue in response to maternal diet (Lan, et al., 2013). Epigenetic 
71 
 
modification is well-described for IGFR2, which regulates adipocyte proliferation and 
differentiation in developing adipose tissue (Holly, et al., 2006). 
In conclusion, understanding the molecular mechanisms of fat deposition and how they can 
be regulated is necessary in order to reduce excess accumulation (Resnyk, et al., 2015). In 
chickens, both hyperplasia and hypertrophy play key roles in adipose deposition. These two 
mechanisms exert dominance at two different time points with an overlap occurring before hatch 
and two weeks post hatch. This study highlights genes in potential pathways that may be regulated 
by the maternal diet enriched in n-3 LCPUFA.  
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 Appendix 
Table 4.1. Summary of reads mapped from RNA Sequencing of abdominal adipose tissue of FO 
and CO chick at 7 and 14 d 
Treatment Age (d) Assigned Ambiguous Alignment not 
Unique 
No feature 
CO 7 19959346 781604.4 2623009 5017301 
FO 7 15356491 616266.8 2083788 3894141 
CO 14 18652824 827766.8 2541828 4416683 
FO 14 18558560 710662.2 2305025 4628521 
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Table 4.2. Genes upregulated in abdominal adipose tissue of FO vs. CO chicks at 7 d 
ENSEMBL ID Gene name Fold change 
(FO/CO) 
p. adj. 
ENSGALG00000004044 cysteine and glycine-rich protein 3 217.66 0.001 
ENSGALG00000006025 xin actin-binding repeat containing 1 162.69 0.001 
ENSGALG00000002988 phosphoglycerate dehydrogenase 2.15 0.001 
ENSGALG00000016300 tubulointerstitial nephritis antigen 93.60 0.001 
ENSGALG00000008914 nebulin-related anchoring protein 147.31 0.001 
ENSGALG00000015602 creatine kinase, mitochondrial 2 223.43 0.001 
ENSGALG00000015018 calsequestrin 2 (cardiac muscle) 185.06 0.001 
ENSGALG00000011086 actin, alpha 1, skeletal muscle 148.68 0.001 
ENSGALG00000014463 actinin, alpha 2 129.51 0.001 
ENSGALG00000007539 ankyrin repeat domain 2 83.97 0.001 
ENSGALG00000018946 leiomodin 3 (fetal) 147.00 0.001 
ENSGALG00000012783 myosin binding protein C, slow type 168.90 0.001 
ENSGALG00000006273 myosin light chain kinase 2 167.51 0.001 
ENSGALG00000011991 myozenin 2 129.35 0.002 
ENSGALG00000026594 heparan sulfate (glucosamine) 3-O-
sulfotransferase 5 
2.82 0.002 
ENSGALG00000006591 troponin I type 2 (skeletal, fast) 96.16 0.002 
ENSGALG00000002907 myosin, light chain 1, alkali; skeletal, 
fast 
155.52 0.002 
ENSGALG00000009844 actin, alpha, cardiac muscle 1 123.39 0.002 
ENSGALG00000005226 myozenin 1 104.93 0.002 
ENSGALG00000005843 eukaryotic translation elongation factor 
1 alpha 2 
80.31 0.002 
ENSGALG00000027771 voltage-dependent calcium channel 
gamma-1 subunit-like 
150.26 0.002 
ENSGALG00000005613 paired-like homeodomain 3 97.82 0.002 
ENSGALG00000001793 myosin, light chain 10, regulatory 142.76 0.002 
ENSGALG00000016309 kelch like family member 31 251.16 0.002 
ENSGALG00000005448 myosin, light chain 3, alkali; 
ventricular, skeletal, slow 
121.39 0.002 
ENSGALG00000019157 small muscle protein, X-linked 177.49 0.003 
ENSGALG00000013634 leucine rich repeat containing 2 124.96 0.003 
ENSGALG00000014847 myomesin 1 41.55 0.003 
ENSGALG00000006572 troponin T type 3 (skeletal, fast) 52.17 0.003 
ENSGALG00000026452 muscle related coiled-coil protein 109.01 0.004 
ENSGALG00000002597 MSS51 mitochondrial translational 
activator 
11.89 0.005 
ENSGALG00000002186 unc-45 homolog B (C. elegans) 193.17 0.005 
ENSGALG00000005292 kelch-like family member 40 61.73 0.005 
ENSGALG00000021340 carbonic anhydrase IX 9.12 0.005 
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Table 4.2. continued 
ENSEMBL ID Gene name Fold change 
(FO/CO) 
p. adj. 
ENSGALG00000010357 purinergic receptor P2Y1 4.98 0.005 
ENSGALG00000028871 solute carrier family 38, member 3 36.42 0.006 
ENSGALG00000015935 SET and MYND domain containing 1 17.31 0.007 
ENSGALG00000012612 fructose-1,6-bisphosphatase 2 34.65 0.007 
ENSGALG00000016127 SH3 domain binding glutamate rich 
protein 
57.84 0.009 
ENSGALG00000006835 troponin C type 2  99.45 0.009 
ENSGALG00000023435 glycine amidinotransferase 35.76 0.009 
ENSGALG00000006216 myogenic differentiation 1 76.37 0.009 
ENSGALG00000023772 heat shock 27kDa protein family, 
member 7  
32.57 0.009 
ENSGALG00000002125 tropomodulin 1 24.64 0.009 
ENSGALG00000005297 hedgehog acyltransferase-like 21.91 0.009 
ENSGALG00000026536 inositol hexakisphosphate kinase 3 121.46 0.009 
ENSGALG00000026875 uncharacterized LOC428186 42.82 0.009 
ENSGALG00000002082 adenosine monophosphate deaminase 1 32.81 0.009 
ENSGALG00000005754 dual specificity protein phosphatase 
22-A-like 
27.92 0.009 
ENSGALG00000005493 integrin beta 1 binding protein 
(melusin) 2 
26.11 0.009 
ENSGALG00000007335 kelch repeat and BTB domain 
containing 13 
8.81 0.009 
ENSGALG00000011094 phosphodiesterase 4B, cAMP-specific 1.93 0.009 
ENSGALG00000008226 NGG1 interacting factor 3 like 1 1.64 0.009 
ENSGALG00000008905 hyaluronan binding protein 2 17.80 0.009 
ENSGALG00000005621 calcium/calmodulin-dependent protein 
kinase II alpha 
77.93 0.010 
ENSGALG00000001459 troponin C type 1  36.92 0.010 
ENSGALG00000016826 ADP-ribosylhydrolase like 1 53.72 0.010 
ENSGALG00000009262 fibrinogen beta chain 4.38 0.011 
ENSGALG00000006491 ankyrin repeat domain 1 (cardiac 
muscle) 
41.76 0.012 
ENSGALG00000004141 liver basic fatty acid binding protein 4.12 0.012 
ENSGALG00000004582 myosin, light chain 2, regulatory, 
cardiac, slow 
146.95 0.012 
ENSGALG00000008805 leiomodin 2 140.89 0.012 
ENSGALG00000028949 coronin 6 47.86 0.012 
ENSGALG00000000164 myosin binding protein H 185.10 0.012 
ENSGALG00000004357 annexin A6 1.25 0.012 
ENSGALG00000006819 ATP/GTP binding protein-like 1 32.14 0.013 
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Table 4.2. continued 
ENSEMBL ID Gene name Fold change 
(FO/CO) 
p. adj. 
ENSGALG00000006508 fibroblast growth factor 13 30.74 0.016 
ENSGALG00000006346 C-X-C motif chemokine ligand 14 5.22 0.016 
ENSGALG00000006008 homer scaffolding protein 2 7.21 0.016 
ENSGALG00000008100 receptor associated protein of the 
synapse 
8.55 0.016 
ENSGALG00000009435 protein phosphatase 1, regulatory 
subunit 3A 
198.82 0.017 
ENSGALG00000007945 crystallin, alpha B 20.30 0.017 
ENSGALG00000016859 methyltransferase like 21E, 
pseudogene 
23.02 0.018 
ENSGALG00000009012 zinc finger protein 385B 9.63 0.019 
ENSGALG00000017316 uncoupling protein 3 15.03 0.020 
ENSGALG00000005537 ankyrin repeat and SOCS box 
containing 14 
16.04 0.020 
ENSGALG00000010614 solute carrier family 25 13.52 0.025 
ENSGALG00000019845 avian beta-defensin 9 5.29 0.026 
ENSGALG00000003925 Myopalladin 18.95 0.027 
ENSGALG00000009082 aarF domain containing kinase 3 2.71 0.030 
ENSGALG00000013056 tubulin, alpha 8a 104.77 0.031 
ENSGALG00000009523 contactin 1 2.31 0.033 
ENSGALG00000014695 chloride channel, voltage-sensitive 1 7.41 0.034 
ENSGALG00000029150 adenylate kinase 1 10.10 0.034 
ENSGALG00000001626 urotensin 2 receptor 9.99 0.035 
ENSGALG00000026395 TraB domain containing 2A 5.89 0.037 
ENSGALG00000009682 ventricular zone expressed PH domain 
containing 1 
4.42 0.037 
ENSGALG00000006300 lactate dehydrogenase A 7.42 0.037 
ENSGALG00000015410 blood vessel epicardial substance 43.97 0.038 
ENSGALG00000005019 dual specificity phosphatase and pro 
isomerase domain containing 1 
16.20 0.039 
ENSGALG00000011324 tubulin alpha 4b 3.45 0.041 
ENSGALG00000012010 N-deacetylase/N-sulfotransferase  3.11 0.044 
ENSGALG00000004840 rabphilin 3A homolog 2.55 0.044 
ENSGALG00000007594 ankyrin repeat and SOCS box 
containing 12 
4.13 0.044 
ENSGALG00000006260 kelch like family member 30 68.27 0.045 
ENSGALG00000011447 glutamate decarboxylase-like 1 15.13 0.045 
ENSGALG00000012845 myosin light chain kinase family, 
member 4 
56.79 0.046 
ENSGALG00000000107 tripartite motif containing 7.1 7.15 0.046 
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Table 4.2. continued 
ENSEMBL ID Gene name Fold change 
(FO/CO) 
p. adj. 
ENSGALG00000016342 myomesin 2 32.44 0.046 
ENSGALG00000013822 taxilin beta 12.35 0.046 
ENSGALG00000003816 5'-nucleotidase, cytosolic IA 10.99 0.046 
ENSGALG00000015937 fatty acid binding protein 1 4.81 0.046 
ENSGALG00000002728 solute carrier family 16 4.96 0.047 
ENSGALG00000012964 ANKH inorganic pyrophosphate 
transport regulator 
1.54 0.048 
ENSGALG00000010826 protein kinase, AMP-activated, alpha 2 
catalytic subunit 
5.93 0.048 
ENSGALG00000009446 leucine-rich single-pass membrane 
protein 1 
7.37 0.048 
ENSGALG00000010881 ankyrin repeat and SOCS box 
containing 2 
5.81 0.053 
ENSGALG00000027090 uncharacterized LOC422926 4.66 0.053 
ENSGALG00000009718 family with sequence similarity 53 
member B 
1.28 0.053 
ENSGALG00000005972 kelch repeat and BTB domain 
containing 12 
28.92 0.055 
Upregulated genes in abdominal adipose tissue at 7 d from N=5 samples per diet group; 
CO, corn oil; FO, fish oil. Adj. P-values are from T-tests, FO vs. CO. Genes represents 
those that were annotated in the chicken genome (Gallus gallus 5.0) 
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Table 4.3. Genes downregulated in abdominal adipose tissue of FO vs. CO chicks at 7 d 
ENSEMBL ID Gene name Fold change 
(FO/CO) 
p. adj. 
ENSGALG00000004621 phosphatidylinositol-3,4,5-
trisphosphate-dependent Rac exchange 
factor 1 
0.58 0.001 
ENSGALG00000021345 UDP-GlcNAc:betaGal beta-1,3-N-
acetylglucosaminyltransferase 9 
0.65 0.002 
ENSGALG00000028895 glucagon receptor-like 0.31 0.002 
ENSGALG00000010046 family with sequence similarity 177, 
member A1 
0.79 0.003 
ENSGALG00000009040 TBC1 domain family, member 8B (with 
GRAM domain) 
0.72 0.005 
ENSGALG00000009158 CDC42 binding protein kinase alpha 
(DMPK-like) 
0.55 0.006 
ENSGALG00000014236 ATPase, aminophospholipid transporter 
(APLT), class I, type 8A, member 1 
0.43 0.007 
ENSGALG00000017405 natriuretic peptide receptor 3 0.45 0.008 
ENSGALG00000014537 Bcl2 modifying factor 0.67 0.009 
ENSGALG00000005914 family with sequence similarity 21, 
member A 
0.69 0.010 
ENSGALG00000011104 Glucagon 0.65 0.010 
ENSGALG00000014938 abhydrolase domain containing 3 0.47 0.011 
ENSGALG00000000723 syntaxin 12 0.80 0.015 
ENSGALG00000011241 raftlin, lipid raft linker 1 0.65 0.016 
ENSGALG00000011533 X-ray repair complementing defective 
repair in Chinese hamster cells 3 
0.70 0.016 
ENSGALG00000011621 insulin like growth factor 2 receptor 0.66 0.018 
ENSGALG00000004727 unc-51 like autophagy activating kinase 
2 
0.61 0.022 
ENSGALG00000027579 mitochondrial ribosomal protein S6 0.72 0.030 
ENSGALG00000007710 ras-like protein family member 11A-
like 
0.61 0.035 
ENSGALG00000014166 translocator protein (18kDa) 0.79 0.036 
ENSGALG00000011153 lymphocyte antigen 75 0.69 0.036 
ENSGALG00000009689 paraoxonase 2 0.71 0.038 
ENSGALG00000009248 heat shock 70kDa protein 12A 0.77 0.046 
ENSGALG00000020557 lysine demethylase 4C 0.76 0.047 
ENSGALG00000010537 cyclin-dependent kinase inhibitor 2C 0.72 0.047 
Downregulated genes in abdominal adipose tissue at 7 d from N=5 samples per diet 
group; CO, corn oil; FO, fish oil. Adj. P-values are from T-tests, FO vs. CO. Genes 
represents those that were annotated in the chicken genome (Gallus gallus 5.0)  
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Table 4.4. Genes upregulated in abdominal adipose tissue of FO vs. CO chicks at 14 d 
ENSEMBL ID Gene Name Fold change 
FO/CO 
p. 
adj.  
ENSGALG00000035219 Albumin 5.42 0.001 
ENSGALG00000000044 WAP, follistatin/kazal, immunoglobulin, 
kunitz and netrin domain containing 1 
5.85 0.001 
ENSGALG00000021040 hydroxyacylglutathione hydrolase-like 1.82 0.001 
ENSGALG00000041926 hexamethylene bisacetamide inducible 1  1.35 0.002 
ENSGALG00000036805 spectrin beta, erythrocytic 1.88 0.005 
ENSGALG00000006491 ankyrin repeat domain 1 (cardiac muscle) 36.26 0.006 
ENSGALG00000006134 4-hydroxy-2-oxoglutarate aldolase 1 10.30 0.006 
ENSGALG00000001926 heat shock protein family B (small) 
member 1 
2.18 0.007 
ENSGALG00000005996 fibronectin type III and SPRY domain 
containing 2 
2.77 0.012 
ENSGALG00000003243 RAD54-like 2 (S. cerevisiae) 1.50 0.025 
ENSGALG00000046217 PIT54 protein 9.24 0.027 
ENSGALG00000000104 cryptochrome 4 1.40 0.031 
ENSGALG00000001264 plexin A2 1.59 0.036 
ENSGALG00000008905 hyaluronan binding protein 2 15.07 0.039 
ENSGALG00000001369 hydroxysteroid (11-beta) dehydrogenase 
1b 
2.10 0.043 
ENSGALG00000009450 dual specificity phosphatase 10 1.47 0.043 
ENSGALG00000009844 actin, alpha, cardiac muscle 1 20.32 0.048 
ENSGALG00000015937 fatty acid binding protein 1 5.94 0.048 
ENSGALG00000001626 urotensin 2 receptor 5.30 0.048 
ENSGALG00000042491 histone cluster 4 H4 2.86 0.048 
ENSGALG00000007383 heat shock protein family B (small) 
member 8 
2.68 0.048 
ENSGALG00000004727 unc-51 like autophagy activating kinase 2 1.52 0.048 
ENSGALG00000007205 cytochrome c oxidase subunit VIa 
polypeptide 1 
1.23 0.048 
Upregulated genes in abdominal adipose tissue at 14 d from N=5 samples per diet group; 
CO, corn oil; FO, fish oil. Adj. P-values are from T-tests, FO vs. CO. Genes represents 
those that were annotated in the chicken genome (Gallus gallus 5.0) 
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Table 4.5. Genes downregulated in abdominal adipose tissue of FO vs. CO chicks at 14d 
ENSEMBL ID Gene Name Fold 
change 
FO/CO 
p. adj. 
ENSGALG00000042396 solute carrier family 12 member 7 0.72 0.001 
ENSGALG00000037203 catenin beta 1 0.87 0.001 
ENSGALG00000011566 glycophorin C 0.71 0.003 
ENSGALG00000030613 platelet derived growth factor receptor beta 0.80 0.003 
ENSGALG00000004230 lipase C, hepatic type 0.06 0.019 
ENSGALG00000016419 Ankyrin repeat and PH domain 2 0.76 0.027 
ENSGALG00000010949 glycoprotein nmb 0.05 0.027 
ENSGALG00000000529 LIM domain containing 2 0.58 0.036 
ENSGALG00000034502 stearoyl-CoA desaturase 5 0.66 0.043 
ENSGALG00000001017 WD repeat containing, antisense to TP73 0.79 0.046 
ENSGALG00000010435 RAS guanyl releasing protein 3 (calcium 
and DAG-regulated) 
0.72 0.048 
Downregulated genes in abdominal adipose tissue at 14 d from N=5 samples per diet 
group; CO, corn oil; FO, fish oil. Adj. P-values are from T-tests, FO vs. CO. Genes 
represents those that were annotated in the chicken genome (Gallus gallus 5.0)  
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Figure 4.1. Hierarchical clustering separates chicks according to diet and age. The 50 most variable 
genes between the four groups were analyzed using Pearson’s correlation. Distance between 
samples and genes were determined using complete linkage. 
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CHAPTER V. 
TRANSCRIPTOMIC AND METABOLOMIC PROFILING OF CHICKEN ADIPOSE 
TISSUE: DUAL PURPOSE BENEFIT FOR HUMAN OBESITY AND POULTRY 
PRODUCTION  
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A version of this chapter was submitted for publication by: Ronique C. Beckford, Eric D. 
Tague, Shawn R. Campagna and Brynn H. Voy Transcriptomic and Metabolomic Profiling of 
Chicken Adipose Tissue: Dual Purpose Benefit for Human Obesity and Poultry Production  
Abstract 
Domestic chickens are a valuable yet underutilized set of model organisms for studies 
relevant to human obesity and adipose metabolism. Chickens and humans share similarities in 
adipose tissue lipid metabolism, and the in ovo development of the chick enables studies of adipose 
development that are difficult to perform in other organisms. Fundamental understanding of 
adipose biology is also important for the poultry industry because broiler (meat-type) chickens are 
prone to obesity due to consequences of genetic selection for rapid growth. Transcriptomic and 
metabolomic studies have begun to characterize adipose metabolism in chickens, yielding 
important insight into mechanisms that control adipose deposition and of leanness. These findings 
are relevant for both understanding obesity in humans, and for addressing the excess deposition of 
adipose tissue that plagues commercial broiler production. This review highlights what has been 
learned about the molecular basis for adipose deposition in chickens using a combination of 
transcriptomics and metabolomics.  
Key words: Adipose tissue, microarray, obesity 
Introduction 
Poultry consumption in the United States more than doubled between 1970 and 2007, 
driven in part by health-conscious consumers seeking a leaner alternative to other meats. 
Paradoxically, selection of broilers for rapid growth has allowed the industry to meet the increased 
demand, but has inadvertently increased fat content of the marketable product (Griffin, et al., 
1994). For example, the widely used Cobb 500 modern broiler strain was shown to have twice as 
much relative breast weight but three times as much relative abdominal fat pad weight than Athens 
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Cobb Random Bred birds, which have been maintained to represent meat-type birds prior to 
genetic selection (Collins, et al., 2014). Excess fat deposition essentially wastes feed, increasing 
costs to growers. Beyond the cost of excess feed, carcass fat is an economic liability due to costs 
associated with processing and with trimming retail cuts to meet consumer preference for a lean 
protein source. In addition to broilers, excess fat is a concern for the egg-producing and broiler-
breeder segments of the poultry industry because it impairs fertility and immune function (Siegel, 
et al., 2003). Systemic effects of excess fat may also impair skeletal muscle energy metabolism 
and compromise the efficient growth of lean tissue. Broiler chickens are also a valuable model 
organism for studies of adipose tissue metabolism and obesity in humans (Voy, et al., 2015). Avian 
and human (but not rodent or ruminant) lipid synthesis is similar in that liver is the primary 
lipogenic tissue (Leveille, et al., 1975). Chickens are also naturally hyperglycemic and insulin 
resistant, comparable to a prediabetes state(Simon, 1989). Finally, heritable susceptibility to 
obesity in broiler chickens is a polygenic trait, which is reflective of the majority of obesity in 
humans (Ikeobi, et al., 2002). Therefore, an enhanced understanding of the molecular and cellular 
pathways that regulate adipose deposition in chickens may yield dual benefit for both production 
agriculture and for human obesity.  
Adipose tissue development 
Chickens store energy as lipids in both subcutaneous and abdominal adipose depots. 
Subcutaneous fat is deposited mainly in the femoral and neck region and becomes visible in the 
embryo at approximately eight to ten days of age. The majority of excess adipose tissue in broilers 
is contained within the abdominal depot, which begins to develop a few days after hatch and is 
visually apparent by five to seven days of age. Abdominal adipose deposition proceeds rapidly 
through increases in both adipocyte number (hyperplasia) and size (hypertrophy). Hyperplasia is 
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the dominant mechanism of fattening in the first two to three weeks of life, after which hypertrophy 
increases rapidly and underlies most of the adipose deposition that occurs from four weeks of age 
to market (Leclercq, 1984). Adipocyte hypertrophy results from uptake and storage of circulating 
lipids that originate from de novo synthesis in the liver, and from the diet (Leveille, et al., 1975; 
O'Hea, et al., 1968). Under a typical commercial poultry diet, in which the relatively low amount 
of dietary fat does not suppress lipogenesis, most stored fatty acids are synthesized in the liver. 
Circulating VLDL molecules transport fatty acids from the liver to adipose tissue, where they are 
cleaved by lipoprotein lipase, transported into the adipocyte, re-esterified with glycerol and stored 
as triglyceride.  
While the role of liver in control of fattening is well-established, adipose tissue actively 
influences its own mass through local and systemic actions that are coupled to metabolism and 
transcription within adipose tissue (Havel, 2000). Adipose tissue communicates with other 
peripheral tissues and the brain through release of metabolites, hormones and peptides into the 
circulation (Trayhurn, et al., 2005).  Components of the adipose secretome regulate feed intake, 
insulin sensitivity, and many other functions that synergize to maintain energy balance (Luo, et 
al., 2016; Pardo, et al., 2012; Peinado, et al., 2012). Production and release of many of these 
secreted factors is directly tied to adipocyte metabolism and size through transcriptional 
mechanisms and metabolic feedback metabolites (Lehr, et al., 2012; Ren, et al., 2012; Schwartz, 
et al., 1997). Therefore, thorough characterization of the adipose tissue metabolome and 
transcriptome is critical towards understanding the control of adiposity in any species, including 
chicken.  
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Models of differential fatness 
Much of what is known regarding mechanisms of fattening in chickens has resulted from 
the study of genetic lines that differ in fatness due to phenotypic selection. Divergent selection is 
particularly effective in chickens due to the extensive sequence variation and high frequency of 
recombination within the chicken genome (Wong, et al., 2004). The most dramatic example of the 
efficiency of selection is the set of high weight (HWS) and low weight (LWS) lines developed by 
Siegel (Dunnington, et al., 1996). After thirty-seven generations of selection, body weight differed 
between these two lines by ~ 8-fold, with marked differences in feed efficiency, body composition, 
egg production, growth hormone, and immune-competence (Siegel, et al., 2003). Divergent 
selection has been used to produce various experimental lines of chickens that differ in fatness. 
Groups with significant differences in adiposity have been produced by selection on plasma VLDL 
level (i.e., hepatic delivery of lipids), plasma glucose level and residual feed intake, as well as 
directly on abdominal fat mass (Buyse, et al., 1992; Hermier, et al., 1984; Hermier, et al., 1991; 
Leclercq, et al., 1987). Only a few generations of selection are necessary to yield significant 
differences in adiposity. For example, relative adipose mass differed by approximately 2-fold by 
the third generation in the French Fat line (FL) and Lean Line (LL) chickens, which were produced 
by selection on abdominal adipose mass (Hermier, et al., 1984).  
Omics approaches to understand adipose deposition 
Transcriptomics: Global gene expression analysis has largely moved from microarrays to 
RNA sequencing (RNAseq). RNAseq enables digital quantification of gene expression through 
the ability to count transcripts associated with each gene in the genome. Methods for RNAseq have 
become relatively standard, particularly due to the prevalence of commercial kits for RNA 
isolation and library construction. Originally, RNA sequencing primarily focused on quantifying 
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protein-coding mRNA sequences. More recently, the evolving recognition that smaller, non-
coding RNAs play important regulatory roles has prompted the use of specific RNA isolation and 
library preparation methods that allow this population of RNAs to be sequenced and quantified 
along with longer, coding transcripts. Transcriptome studies often identify hundreds of genes that 
are differentially expressed, raising the challenge of extracting biological meaning from the data. 
Pathway discovery is enabled by informatics-based geneset enrichment tools, such as the Database 
for Annotation, Visualization and Integrated Discovery (DAVID) (Huang, et al., 2008). These 
tools take as input a set of genes, such as a list of differentially expressed genes, annotate them 
functionally using Gene Ontology (GO) terms and known pathway (e.g., KEGG) membership, and 
then identify functions and pathways that are statistically over-represented compared to what 
would be expected by chance based on comparisons to the species’ corresponding genome or to 
all genes on the array used. 
Metabolomics and lipidomics: An inherent assumption of using transcriptomics to 
understand metabolic physiology is that metabolism can be inferred by querying expression of 
genes that are involved in energy metabolism. Metabolomics and lipidomics are approaches that 
directly profile metabolic consequences by globally measuring metabolites themselves, rather than 
the expression of enzymes that catalyze their production. Conceptually, both metabolomics and 
lipidomics share the goal of comprehensively profiling the abundance of cellular metabolites.  
However the disparate chemical properties of molecules comprised in the metabolome and 
lipidome dictate very different extraction and detection methods, resulting in bifurcation into the 
two sub-disciplines of metabolomics and lipidomics (Dettmer, et al., 2007) .  
Metabolomic studies fall into two broad classes, targeted and untargeted analyses (Patti, et 
al., 2012). Targeted metabolomics is designed to look specifically for known compounds or 
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biomarkers of interest. These are often carried out on instruments such as triple quadrupole mass 
spectrometers where selectivity can be achieved using tandem mass spectrometry wherein each 
metabolite is detected using very specific parent mass and fragmentation patterns. These 
experiments, while limited in the overall scope of molecules detected, are very useful for 
quantification through the use of selected reaction monitoring protocols and internal standards 
(Lang, et al., 2010; Yerramsetty, et al., 2013). Advances in instrumentation, such as the quadrupole 
orbitrap (Q-Exactive , Thermo Scientific), will continue to expand the scope of  targeted 
experiments as high resolution mass analyzers enable metabolite identification from untargeted 
data based on MS/MS fragments (Kouassi Nzoughet, et al., 2017). 
Untargeted metabolomics involves analyzing samples in a “shotgun” approach where a 
broad mass to charge (m/z) window is scanned as the sample is analyzed to detect as many 
molecules as possible. By modifying parameters like extraction solvent, mobile phases, columns, 
and ionization source it is possible to capture the changes of hundreds of metabolites within a 
single untargeted analysis (Patti, 2011). The advancement in the sensitivity and mass accuracy of 
high-resolution mass spectrometers is making untargeted analyses more routine, and it is now 
becoming feasible to achieve good levels of quantitation during untargeted experiments (Lu, et al., 
2010). In addition to identifying chromatographic peaks based on exact masses and retention times, 
untargeted data can be mined for spectral features that represent metabolites but are not currently 
annotated in a database. Features that are quantitatively affected by a treatment of interest (e.g., 
those that differ between fat vs. lean adipose tissue) or that correlate with known metabolites of 
interest can then be probed for putative chemical composition and structure using orthogonal 
methods.  
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Platforms for lipidomics are much more developed than metabolomics because of their 
more uniform structural properties and composition. Lipidomics methods are subdivided based on 
head group, water solubility, and/or polarity further requiring different techniques for proper 
identification (Wenk, 2005). Phospholipids (PL) can be identified by head group and combined 
fatty acid composition using liquid Chromatography-Mass Spectrometry (LC-MS) because of their 
aqueous solubility, but the composition of each fatty acid tail and position of double bonds within 
those fatty acids cannot be discriminated. Gas Chromatography-Mass Spectrometry (GC-MS) can 
provide details about length and location of unsaturation on each tail of a PL (Castro-Gomez, et 
al., 2017). Samples must be derivatized to the FAME (Fatty Acid Methyl Ester) before being 
analyzed (Basconcillo, et al., 2008). 
Several compound databases, such as LIPID Metabolites and Pathway Strategy 
(http://www.lipidmaps.org), the Human Metabolomics Database (http://www.hmdb.ca), and the 
METLIN Metabolite Database (http://metlin.scripps.edu), serve as catalogs for identification of 
from mass spectrometric analyses. Bioinformatics resources such as the Kyoto Encyclopedia of 
Genes and Genomes (http://www.genome.jp/kegg/), and Interactive Pathway Explorer IPath 2.0 
(Yamada, et al.), (http://pathways.embl.de/) are useful for mapping compounds in relevant 
biochemical pathways. Metaboanalyst (www.metaboanalyst.ca), provides end users a web 
interface to process, normalize, and plot metabolomics data while recent updates have added 
features integrating pathway analysis for metabolites and genes. The Small Molecule Pathway 
Database (www.smpdb.ca) uses a visually appealing cellular map to link metabolites, enzymes, 
and their interactions to one another. 
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Insight into control of adipose tissue growth and metabolism in chickens from 
transcriptomics and metabolomics 
Recent transcriptomic studies of adipose tissue have provided valuable insight into 
metabolic pathways that contribute to adipose deposition in chickens (Huang, et al., 2015; Ji, et 
al., 2014; Resnyk, et al., 2015; Zhuo, et al., 2015). A unique feature of these studies when 
considered collectively is that the genetic backgrounds and underlying basis for differences in 
fatness differ considerably between studies, creating the ability to robustly associate molecular 
pathways to fatness. The French FL and LL lines have been intensively studies during the ~ 35 
years since their initial selection (Baeza, et al., 2013). These lines were produced from commercial 
flocks by divergent selection on abdominal fat pad weight (Leclercq, 1984; Leclercq, et al., 1990). 
The FL birds have approximately 2.5X as much abdominal adipose tissue but lower breast muscle 
mass than LL birds.  Food intake and growth rates are similar between the two lines, but FL birds 
are hypoglycemic and hypertriglyceridemic compared to LL. Plasma VLDL levels are predictably 
higher in FL than LL birds, but not until five weeks of age. Adipocyte hypertrophy and hyperplasia 
appear earlier, and are apparent in FL vs. LL as early as two weeks of age (Hermier, et al., 1989). 
This set of lines therefore highlights the fact that intrinsic differences in adipose tissue contribute 
significantly to fattening, in addition to contributions made by liver.  
An initial transcriptomic study with these lines was performed using a custom EST 
microarray (Del-Mar 14K Chicken Integrated Systems microarray (NCBI GEO Platform # 
GLP1731)), over a range of ages (1, 3, 5, 7, 9 and 11 weeks of age) (Resnyk, et al., 2013). Genes 
that were differentially expressed between the two lines, regardless of age, were enriched in 
functions related to lipid metabolism, especially at seven weeks of age and beyond. A follow-on 
study using the same set of birds employed RNAseq to expand identification of differentially 
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expressed transcripts at seven weeks (Resnyk, et al., 2015). Pathway analysis highlighted both 
adipogenesis and fatty acid synthesis as contributors to differences in adiposity. Genes in a diverse 
set of pathways (e.g., axonal guidance, glucocorticoid signaling, various developmental 
pathways), in addition to lipid metabolism, differed between the two lines. In particular, a number 
of genes involved in hemostasis were differentially expressed, with upregulation of genes that 
promote coagulation and thrombosis in LL birds. The authors proposed that these proteases may 
regulate fat deposition through processing of peptides and hormones that are secreted by 
adipocytes. Both fatty acid synthase (FASN) and stearoyl-CoA desaturase (SCD) were 
significantly upregulated in adipose tissue of FL vs. LL birds. Fatty acid synthase catalyzes the 
successive reaction steps of de novo lipogenesis that synthesize palmitate from glucose, while SCD 
introduces a double bond into palmitate. Increased expression of FASN and SCD in FL adipose 
tissue suggests that de novo lipogenesis in adipocytes contributes to excess adipose deposition. 
This possibility conflicts with the conventional view that lipogenic rates in avian adipocytes are 
too low to impact fat storage (Leveille, et al., 1975). However, its role may be under-estimated, 
and suggests further study. Collectively, comparison of the transcriptomes of FL and LL highlight 
that increased lipid storage impacts multiple components of adipose tissue function.  
Feed efficiency, the ability to convert feed consumed to body weight, is a critical parameter 
for efficient broiler production. Birds with low feed efficiency tend to consume more food than 
birds with high feed efficiency and to preferentially convert feed to adipose tissue rather than breast 
muscle. Zhuo, et al., (2015) used RNAseq to compare the transcriptomes of birds that differed in 
feed efficiency and, as a result, abdominal adipose mass. Residual feed conversion was used as a 
selection trait to identify birds with low (LFE) or high (HFE) feed efficiency. Birds in the LFE 
group had 55% more abdominal fat than HFE birds at 46 d of age. Consistent with older FL and 
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LL birds, many genes involved in fatty acid uptake and triglyceride storage were upregulated in 
LFE birds. Expression of SCD was also increased in LFE vs. HFE adipose tissue, although FASN 
was not described as differentially expressed. Genes in pathways related to cholesterol metabolism 
(e.g., cholesterol synthesis and transport, steroidogenesis), and in the transcription factors (e.g., 
sterol regulatory element binding proteins) that regulate expression of cholesterol metabolizing 
enzymes were also differentially expressed between LFE and HFE. Cholesterol synthesis genes 
were increased in LFE vs. HFE adipose tissue, suggesting that increased cholesterol storage 
contributes to lipid droplet expansion and adipocyte hypertrophy in in LFE birds. In general, the 
pathways that differed between LFE and HFE birds are similar to those differing between FL and 
LL (Resnyk, et al., 2015), despite the marked differences in selection criteria used to produce these 
two sets of study groups. This raises the possibility that feed efficiency and adipose deposition are 
genetically correlated, driven by common molecular pathways. If so, understanding mechanisms 
that underlie adipose deposition may also improve the understanding of feed efficiency.  
Advances in RNAseq technology allow profiling of both coding and small non-coding 
RNA species. Integration of the two types of data enables the simultaneous identification of 
differentially expressed regulatory RNAs and their mRNA targets, and to associate these to 
phenotypes of interest. This strategy has been used to identify miRNAs that regulate expression of 
lipogenic and adipogenic genes, and potentially fat deposition, in chicken’s (Huang, et al., 2015) 
.Birds with high and low abdominal fat pad weights were selected from an F2 cross of Beijing-
You, a slow-growing Chinese breed, and a commercial Cobb-Vantress broiler line. Abdominal 
adipose tissue was for profiling of both miRNA and mRNA using RNAseq. Differential expression 
analysis identified 430 protein-coding genes and 62 miRNAs that differed significantly between 
the two groups of birds. Downstream targets of the miRNAs were predicted and compared to the 
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set of protein-coding genes, identifying 106 miRNA-mRNA pairs that were coordinately 
expressed in lean vs. fat birds. Functional enrichment analysis revealed that the coding genes 
within these pairs were involved in pathways related to both adipocyte hypertrophy (e.g., fatty acid 
synthesis and metabolism) and adipogenesis (Wnt receptor signaling). In vitro experiments 
verified the role of select miRNAs in proliferation and differentiation of chicken preadipocytes. 
This study therefore took RNAseq to the next step by identifying miRNAs that can regulate both 
adipocyte size and number in chickens. Sequencing and characterization of other classes of non-
coding RNAs will almost certainly expand this set of molecular control mechanisms for adipose 
deposition in chickens. To this point, the repertoire of long con-coding RNAs (lncRNAs) that are 
expressed in chicken adipose tissue was recently characterized and correlated with co-expressed 
mRNAs (Muret, et al., 2017). 
Despite variation in the origins and methods used to produce fat and lean lines in each of 
these three studies, each associated upregulation of PPARG with increased adiposity. PPARG 
encodes a transcription factor that plays a dual role in adipose deposition (Brun, et al., 1997). In 
preadipocytes, PPARG orchestrates the transcriptional changes that are required for development 
of a lipid storage phenotype, while in mature adipocytes it is important in maintaining this 
phenotype. At the ages studied (~ 6-7 weeks of age), hypertrophy is the primary mechanism of fat 
deposition in broilers. Therefore increased PPARG expression in these models likely signifies its 
role in mature adipocytes.  However, adipocyte number, which reflects PPARG’s role in 
adipogenesis, is significantly increased in FL vs. LL chicks by approximately two weeks of age, 
well before adipocyte size diverges and prior to increases in plasma VLDL (Baeza, et al., 2013). 
Other adipogenic proteins (e.g., Kruppel-like transcription factor 15, follistatin-like 1), albeit with 
less well-defined roles than PPARG, were also differentially expressed in one or more 
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comparisons of lean vs. fat groups. Upregulation of PPARG may therefore indicate that adipocyte 
number also plays an important role in fat deposition, even in mature birds.  
In contrast to transcriptomics, which was enabled by the development of microarrays in 
the mid-1990s (Bumgarner, 2013), metabolomics has only recently emerged as tool used to query 
physiology. Comparisons of the plasma metabolomes of the French FL and LL lines of chickens 
highlights the insight that can be gained from global metabolite profiles (Baeza, et al., 2015 ). 
Circulating levels of several amino acids were associated with differences in fatness, highlighting 
protein metabolism as an under-appreciated pathway that may contribute to adipose deposition. 
Regression modeling determined that plasma lipids and lipid metabolites (i.e., free fatty acids, total 
cholesterol and phospholipid, β-hydroxybutyrate) combined with glutamine and methionine levels 
explained 74% of variability in abdominal fat pad weight. These relationships illustrate the utility 
of using metabolomics and lipidomics to query the intermediates and end products of cellular 
metabolism, in addition to profiling expression levels of the genes that produce these metabolites. 
Transcriptomics and metabolomics/lipidomics are complementary tools that, when 
combined, can be more informative than either single platform, particularly for studies of 
metabolism. Metabolomics data can be used to validate that changes in gene expression have 
functional consequences on how the tissue allocates energy. They can also prompt further 
investigation of specific changes in expression of genes that may otherwise be overlooked. 
Transcriptomic and metabolomic studies of adipose tissue were combined to identify pathways 
that contribute to increased fatness in broilers compared to naturally lean breeds of chickens (Ji, et 
al., 2014). Two genetically distinct lean lines (meat-type Fayoumi and egg-type Leghorn) with 
approximately 50% less fat than broilers were used to increase the robustness of comparisons. 
Many of the same genes identified in transcriptomic comparisons described above were also 
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differentially expressed between broilers and the lean lines. For example, pyruvate dehydrogenase 
kinase 4 (PDK4), a kinase that promotes oxidation of fatty acids by phosphorylating and 
inactivating pyruvate dehydrogenase, was expressed at higher levels in both LL vs, FL chickens 
and in Fayoumi and Leghorn compared to broilers. Leanness was associated with upregulation of 
genes that regulate the catabolism and oxidation of fatty acids. Fatty acid oxidation in white 
adipose tissue has classically been dismissed as playing an important role in fat accumulation 
because rates are relatively low compared to highly oxidative tissues like skeletal muscle. 
However, growing evidence in mice and humans indicates that activation of this pathway reduces 
adipocyte size and inflammation (Kusminski, et al., 2012; Marcelin, et al., 2010). Parallel 
metabolomic profiling complemented the transcriptomic results by revealing that carnitine and 
acetylcarnitine, which traffic fatty acids intra-cellularly for oxidation, were significantly more 
abundant in adipose tissue of both lean lines vs. broilers (Ji, et al., 2014). Recently, this pathway 
was shown to be rapidly upregulated in response to fasting in young broiler chicks and to be 
coordinately regulated with genes that mediate both adipogenesis and lipogenesis (Ji, et al., 2012; 
Torchon, et al., 2017). Convergent transcriptomic and metabolomic evidence for its role leanness 
underscores the complementarity of these two ‘omics platforms.  
Omics studies have the potential to identify control points that can be manipulated by diet 
or other factors to reduce fatness. Transcriptional and metabolomic profiling have been combined 
to characterize the homeostatic control of adipose metabolism in young broiler chicks in response 
to a brief period (5 hrs) of food deprivation (Ji, et al., 2012) Fasting significantly altered the 
expression of > 1200 genes in abdominal adipose tissue of 21 day-old broiler chicks relative to ad 
libitum fed controls. Many of the same pathways, e.g., lipogenesis, adipogenesis, cholesterol 
synthesis, that differed between fat and lean comparisons were also affected by a short term fast 
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(Figure 1). A number of genes (e.g., carnitine palmitoyl transferase, acyl-CoA oxidase, PDK4) 
that were expressed at higher levels in fasted compared to fed adipose tissue were also upregulated 
in lean lines, suggesting that pathways altered by fasting overlap with those that contribute to 
heritable differences in leanness. Metabolomic profiling of adipose tissue highlighted a number of 
amino acids that were affected by fasting, and several genes involved in protein and amino acid 
catabolism were also differentially expressed in fasted vs. fed bids. Taken together, this suggests 
a role for amino acid metabolism that may not have been appreciated if either dataset was generated 
in isolation. Interestingly this is consistent with differences in plasma metabolomes between FL 
and LL lines (Baeza, et al., 2015).  
Conclusions and future directions 
In addition to its role as a primary source of lean, affordable dietary protein, the domestic 
chicken presents novel opportunities as a model organism for studies relevant to human nutrition 
and obesity. Transcriptomic studies using commercial microarray platforms have provided clues 
into mechanisms of fat development and expansion in this model. Follow-on studies utilizing the 
discovery power of RNAseq have the potential to identify an expanded set of transcripts and 
pathways that are fundamentally important to early adipose tissue development, as well as those 
that promote obesity or maintain leanness. The power of these studies can be expanded in the 
future by integrating transcriptomics with tissue metabolomics and lipidomics to identify both 
molecular pathways and the corresponding effects on adipose metabolism.   
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Appendix 
 
Figure 5.1. Similarities in adipose tissue gene expression profiles between genetically-driven 
leanness and fasting. Unsupervised clustering was used to visualize similarities in gene expression 
profiles from abdominal adipose tissue of fed and fasted (five hours) 21 day-old broiler chicks (Ji, 
et al., 2012), and from fed adult broilers and genetically lean Fayoumi chickens (Ji, et al 2014). 
Expression profiles from fasted broiler chicks were more similar to those of the genetically distinct, 
lean Fayoumi line than to profiles from chick or adult broilers that were fed.  
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CHAPTER VI.  
CONCLUSION AND FUTURE DIRECTIONS  
This study utilized a novel approach to provide the developing embryo with omega 3 
polyunsaturated fatty acids. The primary goal was to determine the resultant effect on adipose 
tissue development and metabolism in the offspring. Feeding broiler breeder hens a diet enriched 
in long chain polyunsaturated omega 3 fatty acids was sufficient to alter the fatty acid milieu of 
the yolk consequently influencing the phospholipid profile of the brain, liver, and adipose tissue 
of the chicks at hatch. Post hatch, chick performance up to two weeks old was not altered. Despite 
no differences in growth and adiposity, FO chicks had a higher frequency of smaller adipocytes 
compared to the CO chicks. Though the levels of eicosapentaenoic acid and docosahexaenoic acid 
decreased significantly at 14 days the impact on adipocyte size and gene expression was still 
evident. QPCR results found that lipoprotein lipase expression was reduced while the expression 
of the transcription factor PPARγ and its co-activator PPARγGC1β was increased in the FO chicks. 
This suggests that there was an increase in adipogenesis and a reduction in uptake of fatty acids in 
the FO chicks. Profiling the proteome and transcriptome indicated that FO chicks may also have a 
reduction in gluconeogenesis, lipid metabolism, and lipid trafficking in the adipocyte. Though we 
anticipated that there would be an impact on fatty acid oxidation, there were no differences in the 
expression of marker genes in the peroxisome and the mitochondria. Combined, these results 
suggests that early exposure of the developing embryo to long chain omega 3 polyunsaturated fatty 
acids through the maternal diet may be a way to address excess fat deposition in the offspring. 
Though novel, this approach identifies a number of potential mechanisms that would warrant 
further investigation. Understanding these mechanisms and how they can be regulated could be 
beneficial to both humans and poultry. From a medical point of view, suppressing fat deposition 
in humans will reduce the onset of obesity and its associated co-morbidities. On the other hand, 
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reducing excess fat deposition in chicks would improve feed efficiency and decrease processing 
cost. Since this study was conducted for two weeks post hatch, it may be necessary to lengthen the 
duration and combine this method with another feeding regime to sustain its impact over a longer 
time period. Therefore future studies are needed to determine how much longer this effect would 
remain and what approach could be used to enhance its effect. For example, fasting may be 
required to increase utilization. Also if this method was to be translated to humans, identifying the 
appropriate time of consumption during pregnancy, length of exposure, and the required intake to 
obtain a substantial impact would be important.  
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APPENDIX 
Enriching the starter diet in Omega 3 polyunsaturated fatty acids reduces adipocyte size in 
broiler chicks 
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Abstract 
Epidemiological studies associate perinatal intake of eicosapentaenoic acid (EPA, 20:5, n-
3) and docosahexaenoic acid (DHA, 22:6, n-3)) with reduced adiposity in children, suggesting that 
these fatty acids may alter adipose tissue development. The objective of this study was to determine 
if enriching the perinatal diet in EPA and DHA reduces fat deposition in juveniles. Cobb 500 
broiler chicks were fed isocaloric diets containing fat (8% wt:wt) from fish oil (FO), lard (LA), 
canola oil (CA), or flaxseed oil (FL) from 7 to 30 d of age. Adiposity (abdominal fat pad wt/body 
wt) at 30 d was not significantly affected by diet, but FO significantly reduced adipocyte size, 
increasing the abundance of small adipocytes. Plasma non-esterified fatty acid (NEFA) levels 
suggest that reduced adipocyte size was due in part to enhanced mobilization of fatty acids from 
adipose tissue. Our work indicates that dietary EPA and DHA effectively reduce the size of 
developing adipocytes in juveniles, which may limit adipose deposition and provide metabolic 
benefits. 
Keywords: Childhood obesity, Obesity, Fatty acids, Adipose tissue, Model Organism 
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Introduction 
Approximately 27% of children in the U.S. are classified as overweight or obese by age 
five (Cunningham, et al., 2014). Obese children are more likely to be obese adults, and both 
childhood and adult obesity increase the risk of cardiovascular disease, diabetes and other co-
morbidities (Freedman, et al., 2001). Limiting excess fat accumulation in the first few years of life 
is therefore therapeutically important for children and for prevention of adult obesity. A plethora 
of studies have identified factors that influence adiposity in mature animals and humans, in which 
changes in adipocyte size are the primary basis for differences in fatness. Much less is known 
about control of adipose mass in juveniles, when both adipocyte hypertrophy and hyperplasia 
actively contribute to fat deposition.  
Polyunsaturated fatty acids of the n-3 and n-6 series differentially regulate preadipocyte 
proliferation, adipogenesis, and triglyceride storage, all of which contribute to deposition of 
adipose tissue prior to adolescence. Omega-6 PUFAs tend to be pro-adipogenic, while LC n-3 
PUFAs (particularly EPA and DHA) attenuate lipid accumulation and promote an oxidative 
adipocyte phenotype (rev. in (Kopecky, et al., 2009)) Large-scale studies in mother-child pairs 
have associated n-6 PUFA intake with increased adiposity in children, while an inverse 
relationship has been demonstrated with dietary n-3 PUFA (Donahue, et al., 2011; Vidakovic, et 
al., 2016). These associations suggest that the types of fatty acids consumed early in life may 
influence the course of adipose development and subsequently impact the predisposition for 
obesity. 
Avian models are useful for testing the effects of diet on early adipose development 
because chicks eat independently at hatch, allowing direct manipulation of the diet very early in 
life. Broiler chickens in particular are a valuable, polygenic model of susceptibility to obesity due 
to inadvertent consequences of selection for rapid growth (Cartwright, 1991). Broiler chicks begin 
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to deposit excess abdominal fat compared to other breeds within two weeks of hatch. In contrast, 
most rodent models of obesity are monogenic, or are induced by feeding a diet very high in fat. 
We used Cobb 500 broiler chicks, one of the most widely-used commercial broiler lines, to 
determine if providing EPA and DHA in the diet early in life attenuates adipose tissue deposition 
in juveniles. Diets enriched in fish oil (as a source of EPA and DHA) were compared to diets 
containing equal amounts of lard, canola oil, or flaxseed oil to evaluate the effects relative to other 
types of fatty acids. Experimental diets were provided beginning at seven days of age to coincide 
with initial deposition of the abdominal depot, and to focus on a developmental window in which 
hypertrophy and hyperplasia contribute comparably to adipose growth.  
Materials and Methods 
Animals and diets  
All animal procedures were approved by the University of Tennessee Institutional Animal 
Care and Use Committee. Forty mixed-sex Cobb 500 broiler chicks were fed ad libitum a 
commercial starter diet from hatch until 7 d, then switched to one of four experimental diets. 
Experimental diets were produced by adding fat (8% wt:wt) from lard (LA), canola oil (CA), 
flaxseed oil (FL) or fish oil (FO) into a commercially-formulated starter diet base. Final energy 
content of each diet was 3018 Kcal/kg. Chicks were fed experimental diets from 7 to 30 d. At 30 
d, chicks were weighed, then euthanized by CO2 asphyxiation, and tissues and blood were 
collected for experimental procedures. Complete experimental details are provided in 
Supplemental Information.  
Statistical analysis 
Data were analyzed for effects of diet using ANOVA, implemented in SAS (version 9.4, 
SAS Institute Inc., Cary, NC) with P < 0.05 as the criterion for statistical significance. A significant 
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F-test was followed by post-hoc comparisons using Fischer’s least significant difference (LSD) to 
identify pairwise differences between diet groups.  
Results 
Effects on body composition and growth rate 
Fatty acid composition of the diet significantly affected final body weight (P = 0.045), with 
FO birds weighing less than those in the LA group (Table 1, P = 0.02). Neither absolute nor relative 
(adjusted for body weight) weights of the abdominal adipose depot or of breast muscle differed 
significantly between diet groups (P > 0.05). Plasma levels of NEFA (P = 0.002), but not glucose 
(P = 0.130) were affected by diet, with increased NEFA in FO chicks compared to each of the 
other diet groups. As expected, the fatty acid profile of the abdominal fat reflected the dietary fatty 
acid composition (Supplemental Table 1). Feed intake did not differ across diets (data not shown).  
Despite similarities in fat pad weight, diet significantly affected abdominal adipocyte 
volume (P = 0.020). Average adipocyte size was smallest in FO chicks, differing significantly from 
chicks fed LA or CA diets (Table 1). Adipocyte number varied with diet (Table 1), but differences 
were not statistically significant (P = 0.093). Fish oil promoted a shift in adipocyte size, favoring 
the abundance of relatively small adipocytes compared to diets enriched in LA or CA (Figure 1A). 
The frequency of very small (< 2000 μm3) adipocytes was significantly increased in FO vs. either 
LA or CA (P < 0.05). Conversely, frequencies of cells in each size bin beyond 4000 μm3 were 
lower (P < 0.05) in FO vs. CA, and in FO vs. LA for most bins. Adipocyte volumes tended to be 
smaller in chicks fed the FL diet, with frequencies intermediate between those of FO and LA or 
CA in most size bins.  
Effects on Relative mRNA Expression in Visceral White Adipose Tissue and Liver 
Dietary fat source significantly influenced expression of PPAR gamma (PPARG), early 
growth response transcription factor 1 (EGR1), patatin-like phospholipase domain containing 
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protein 8 (PNPLA8), and pyruvate dehydrogenase kinase 4 (PDK4) in abdominal adipose tissue 
(Figure 1B). Both PPARG and EGR1 were expressed at significantly lower levels in FO and CA 
chicks relative to LA. Expression of PNPLA8 was significantly reduced in FO, CA and FL 
compared to LA. Genes associated with fatty acid oxidation (acyl-coenzyme A oxidase 1 
(ACOX1) and carnitine palmitoyl acyltransferase 1 (CPT1)), lipogenesis (fatty acid synthase 
(FASN)), lipid storage (lipoprotein lipase (LPL)), gluconeogenesis (phosphoenolpyruvate 
carboxykinase 1 (PCK1)), and inflammation (chemokine C-C ligand 20 (CCL20), colony 
stimulating factor 1 receptor (CSF1R)) were not significantly affected by dietary fat type. In liver, 
expression of ACOX1, but not CPT1 or FASN, was significantly affected by diet (Figure 1C). 
Expression of ACOX1 was higher in FO vs. all other diet groups. 
Discussion  
A number of studies in rodents have shown that dietary fish oil can attenuate the obesogenic 
effects of a high fat diet. These studies have largely used mature animals, in which growth-related 
adipose expansion has ceased and changes in adipose mass result from effects on adipocyte size. 
In contrast, we focused on the first few weeks after hatch to capture the period when the abdominal 
depot develops and rapidly expands through both adipocyte hyperplasia and hypertrophy (Deaton, 
et al., 1985). Evaluating the effects of fish oil on these pathways is important because both 
contribute to childhood obesity (Landgraf, et al., 2015; Spalding, et al., 2008). A specific benefit 
of using an avian model, compared to rodents, is that they lack UCP-1 and thus the capacity for 
adipose browning. This is valuable because recent studies indicate that at least part of the anti-
obesity effects of fish oil in rodents are due to induction of beige adipocytes in white adipose 
depots (Kim, et al., 2015). Therefore our model enables us to evaluate the specific effects of dietary 
FO on white adipocytes.  
113 
 
Unlike comparable diet studies in mature chickens e.g., (Gonzalez-Ortiz, et al., 2013), we 
did not find an effect of dietary n-3 PUFA on adiposity. This may be due to the relatively brief 
period of feeding (23 days), or because fatty acid type was not sufficient to influence the inherent 
stimulus for rapid adipose deposition during this age window. However, diets that were enriched 
in n-3 PUFA (particularly FO) favored the abundance of small adipocytes relative to diets enriched 
in LA or CA. Although adipocyte hypertrophy is a normal component of adipose development, 
excessive hypertrophy presents very early in obese children and promotes insulin resistance and 
adipose inflammation (Landgraf, et al., 2015). Therefore, the ability of dietary n-3 PUFA to reduce 
adipocyte size in juveniles, even in the absence of decreased fat mass, may provide metabolic 
benefits for children prone to obesity.  
Adipocyte size results from a balance between fatty acid uptake and mobilization, 
particularly in species (e.g., avians and humans) in which de novo lipogenesis in adipose tissue is 
relatively modest. Increased plasma NEFA levels suggest that enhanced fatty acid mobilization 
may have contributed to reduced adipocyte size in FO chicks. Interestingly, elevated NEFA, 
reduced adipocyte size, and enrichment of adipose tissue in EPA and DHA are also found in 
genetically lean lines of chickens relative to obesity-prone broilers (Ji, et al., 2014). Both DHA 
and EPA have been shown to stimulate lipolysis and reduce adipocyte lipid accumulation in vitro 
(Barber, et al., 2013; Kim, et al., 2006). Consumption of FO may therefore have reduced adipocyte 
size by promoting mobilization of fatty acids that are then oxidized by other tissues. Hepatic 
expression of ACOX1, the rate-limiting enzyme for oxidation of very long chain fatty acids in 
peroxisomes, was increased by dietary FO. However, expression of CPT1, which regulates 
mitochondrial fatty acid oxidation and is often co-regulated with ACOX1, was not significantly 
affected by diet in liver. Therefore increased expression of ACOX1 in the FO group may reflect a 
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specific response to the abundance of very long chain PUFA (EPA and DHA), rather than a net 
increase in hepatic fatty acid catabolism. Dietary EPA has also been shown to enhance fatty acid 
oxidation within white adipocytes (LeMieux, et al., 2015). However, our data do not indicate that 
this pathway contributed to reduced adipocyte size in FO and FL chicks, based on expression of 
CPT1 and ACOX1. It is also possible that FO, and to some extent FL, increased the abundance of 
smaller adipocytes by suppressing their progression through differentiation, rather than altering 
the balance between lipid storage and mobilization.  This possibility is supported by a study in 
which dietary perilla oil (~ 52% ALA) down-regulated the later stages of adipocyte differentiation 
in rats (Okuno, et al., 1997). Additional characterization with stage-specific markers of adipocyte 
differentiation is necessary to investigate this possibility in our study. 
None of the genes that we profiled were specifically affected by the diets (FO and FL) that 
reduced adipocyte size. However, all three diets enriched in unsaturated fatty acids reduced 
expression of PPARG, EGR1 and PNPLA8 compared to LA. PPARG is a well-characterized 
transcriptional regulator of both adipocyte differentiation and maintenance of the mature adipocyte 
phenotype (Chawla, et al., 1994). Increased PPARG expression with dietary SFA vs. PUFA-
enriched diets is consistent with comparable studies in mature broilers (Royan, et al., 2011). EGR1 
is a pleiotropic transcription factor that has been linked to multiple aspects of adipocyte function 
(Singh, et al., 2015). Elevated EGR1 expression in adipose tissue is associated with obesity in 
humans and mice, while loss of EGR1 enhances adipocyte metabolism and confers protection from 
obesity (Zhang, et al., 2013). Decreased expression of this gene in the FL, FO and CA groups 
relative to LA may therefore reflect beneficial effects of dietary fat quality on adipocyte 
metabolism. Calcium-independent phospholipase A2γ (iPLA2γ, encoded by PNPLA8), is a 
phospholipase that catalyzes the release of fatty acid side chains from mitochondrial phospholipids 
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to generate production of eicosanoids and other lipid second messengers that regulate cellular 
energetics . The specific roles of iPLA2γ in adipose tissue are not known, but PNPLA8-/- mice are 
resistant to diet-induced obesity, with reduced adipocyte size relative to wild type controls 
(Mancuso, et al., 2010). Although expression was not consistently associated with adipocyte size 
in our study, reduced levels across all PUFA-enriched diets suggest that dietary fatty acids may 
regulate mitochondrial lipid mediators and subsequently adipocyte metabolism through PNPLA8.  
In conclusion, we have demonstrated that dietary FO attenuates adipocyte hypertrophy in 
juveniles that are prone to rapid fat accumulation. The mechanisms underlying this effect remain 
to be determined, but may include increased mobilization of stored fatty acids for oxidation by 
other tissues or disruption of adipocyte maturation. Although the effect of diet on adipocyte size 
did not manifest as significantly less adipose mass during the relatively brief period of feeding 
used herein, it may nonetheless be sufficient to elicit favorable metabolic effects in children who 
are prone to obesity.  
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Appendix 
Table 1. Effects of dietary LA, CA, FL and FO on body, adipose and muscle weights and on serum 
metabolites in broiler chicks1 
 LA CA FL FO P-value2 
Body (g) 1752 ± 46.7b 1650 ±  54.6ab 1694 ± 45.1ab 1562 ± 45.0a 0.045 
Breast (g) 337.9 ± 13.8 360.2 ± 16.5 354.6 ± 13.6 346.1 ± 7.9 0.573 
Breast (%)3 19.4 ± 1.0 21.9 ± 0.6 21.0 ± 1.0 22.1 ± 1.7 0.400 
Adipose (g) 26.0 ± 1.9 24.5 ± 1.2 22.3 ± 1.2 24.3 ± 1.8 0.455 
Adipose (%)4 1.48 ± 0.09 1.51 ± 0.07 1.33 ± 0.07 1.56 ± 0.12 0.499 
NEFA (mM) 6.25 ± 1.98 b 6.49 ± 0.79 b 6.55 ± 1.41b 10.04 ± 0.96a 0.002 
Glucose (mg/dL) 175.7 ± 12.8 184.5 ± 10.8 189.4 ± 7.0  168.1 ± 5.7 0.130 
Adipocyte 
volume 
3651 ± 420.7a 3706 ± 184.1a 3098 ± 95.2ab 2546 
±153.1b 
0.020 
Adipocyte 
number5 
75.4 ± 13.3 70.8 ± 9.5 93.7 ± 9.8 90.3 ±8.1 0.093 
1LA= Lard; CA=Canola oil; FL=Flax; FO=Fish oil. Data are means ± SEM for all chicks 
in each diet group, N=10/group. Means with shared superscripts do not differ significantly; p<0.05. 
2 P-value from single factor ANOVA for effect of diet 
3 (Breast wt (g)/body wt (g))*100 
4 (Abdominal adipose depot wt (g)/body wt (g))*100 
5 Calculated from adipocyte volume and adipose depot weight 
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Figure 1. Effects of dietary FO, FL, CA and LA on abdominal adipocyte size distribution and on 
gene expression in liver and adipose tissue. (A), Adipocyte area was measured from images of 
H&E-stained sections of abdominal adipose tissue using Image J (Version 1.48, National Institutes 
of Health); areas < 500 μm2 were removed from analyses. Adipocyte volume (μm3) was calculated 
from area (μm2). Frequency distributions were produced by grouping adipocytes into bins based 
on volume and counting the frequency of cells within each bin. ANOVA was used to evaluate the 
effect of diet within each bin. Values with different superscripts differ significantly (P < 0.05) 
based on post-hoc testing when ANOVA indicated a significant effect of diet (P < 0.05); (B, C). 
Relative mRNA expression of genes involved in lipid metabolism, adipogenesis and inflammation 
in abdominal adipose tissue (B), and in lipid metabolism in liver (C) , N=6 birds / diet. Values are 
group means ± group std. dev.; values with different superscripts differ significantly (P < 0.05) 
based on post-hoc testing when ANOVA indicated a significant effect of diet (P < 0.05); Lard 
(LA), Canola Oil (CA), Flaxseed oil (FL), Fish oil (FO).  
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Supplemental Methods 
Animals and experimental diets: Animal husbandry procedures were reviewed and 
approved by the Institutional Animal Care and Use Committee of the University of Tennessee. 
Forty 1-d old mixed sex Cobb 500 broiler chicks were utilized in the study. Birds were raised in 
stacked wire cages under standard management conditions, and had ad libitum access to water and 
feed. For the first six days, birds were fed a standard commercial broiler starter diet. On day seven, 
birds were assigned to one of four diets that differed in the type of added fat. Diets were prepared 
by adding lard (LA) (LA; Refined Lard, Lundy’s, USA), canola oil (CA; Pure Wesson 100% 
Natural, ConAgra Foods Inc., USA), flaxseed oil (FL), and fish oil (FO) (JEDWARDS 
International Inc., Quincy Massachusetts) at 8% (wt:wt) to a standard broiler starter base diet 
formulated primarily from corn and soybean (Table 1). The base diet was mixed in one large batch, 
and the four sources of fat were added to the same base diet. Final energy content of each diet was 
3018 Kcal/kg. Experimental diets (those with added oil) were prepared every five days and stored 
at 4ͼC.to minimize oxidation.  Chicks were maintained on the experimental diets for 23 days (until 
30 d of age). Body weight and feed intake were monitored weekly. 
Chicks were euthanized by CO2 asphyxiation. At the time of euthanasia blood was 
collected by cardiac venipuncture and transferred to 10 ml SST tubes (Fisher Scientific, Pittsburgh, 
PA). Serum was separated by centrifugation and frozen at -80o C until analyses of circulating 
metabolites. Abdominal and femoral (subcutaneous) adipose depots were dissected and weighed 
as indices of adiposity. Breast (pectoralis major) muscle was dissected and weighed to assess 
muscle deposition. Samples of adipose, breast and liver tissue were subsequently snap-frozen in 
liquid nitrogen and stored at -80oC. Samples of abdominal adipose tissue were also fixed for 24 h 
at 4oC in paraformaldehyde (4%) for determination of adipocyte size by histology.  Abdominal fat 
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was removed and submerged in chilled 4% paraformaldehyde in 0.1 molar sodium phosphate 
buffer at pH = 7.4 for tissue fixation. Tubes were incubated at 4qC for 12 hour, washed in sodium 
phosphate buffer at 0.1 molar, and then transferred into chilled sodium phosphate buffer for 
storage. 
Serum metabolites: Commercially available colorimetric assay kits were used to measure 
serum glucose (Cayman Chemical, Ann Arbor, MI) and non-esterified fatty acid (NEFA) levels 
(Wako Chemicals, Neuss, Germany). 
Fatty acid analysis: Abdominal fat from one randomly selected bird for each treatment 
was analyzed for phospholipids (PL), neutral lipids (NL), and total lipids (TL) using gas 
chromatography. Fatty and acids were extracted using a modified Folch method (Ref). Briefly, 
lipids were separated using thin layer chromatography (TLC) plates, pre-coated with silica gel 60 
(Merck, Darmstadt, Germany). Boron tri-fluoride in methanol and heat were used to saponify 
lipids into fatty acid methyl esters (FAME). Hexane was used to extract and dissolve the FAME. 
Fatty acid methyl esters were separated using a Hewlett-Packard 5880 gas chromatograph 
(Rochester, NY) and a DB23 capillary column (0.25 mm × 30 m) (J and W Chromatography, 
Folsom, OH) with hydrogen as the carrier gas. Based on the known internal standard (NuChek 
Prep, Elysian, MN), fatty acids were identified by retention times and fatty acid composition was 
calculated as a mole percentage relative to total fatty acids. 
Adipose tissue histology: Abdominal fat samples from three birds in each diet group were 
embedded, sectioned and stained with hematoxylin and eosin (H&E; two slides/bird) for 
determination of adipocyte size, as previously described by (Ji, et al., 2014). Briefly, images of 
three independent fields were captured on each slide under 20x magnification with the Advanced 
Microscopy Group EVOS XL Core microscope (Fisher Scientific, Pittsburgh, PA). For 
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consistency, the same person performed all measurements. Image J (Version 1.48, National 
Institutes of Health) was used to determine adipocyte area, (μm2), using microscope settings of 2.8 
μm/pixel, and using the restriction that measurements must exceed 500 μm2. Frequency 
distributions were produced by grouping adipocytes into bins based on area and counting the 
frequency of cells within each bin. Adipocyte number was estimated based on average adipocyte 
volume and on weight of the adipose depot.  
Real time PCR assay: Total RNA was isolated from approximately 200 mg of abdominal 
adipose tissue and liver from five chicks in each treatment using InvitrogenTM TRIzolTM 
(Invitrogen, Carlsbad, CA). CDNA was synthesized from 500 ng total RNA in 20 μl reactions 
using iScript cDNA Synthesis kit (Bio-Rad Laboratories, Hercules, CA). Predesigned and 
validated primers for quantitative real-time PCR (QPCR) were purchased from Qiagen 
(Quantitect; Germantown, MD). QPCR was performed in triplicate for each sample using iQ 
SYBR Green Master Mix (Bio-Rad Laboratories, Hercules, CA), as previously described (Ji, et 
al., 2014). Expression levels of genes of interest were normalized to expression of TBC1 domain 
family, member 8 (TBC1D8) used as a housekeeper.  
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Table S.1. Base experimental diet composition 
Ingredient Amount 
(%,)1 
Corn 56.76 
Soybean meal 31.94 
Vitamin Premix2 0.05 
Choline  0.20 
DL Met  0.10 
Salt 0.30 
Limestone 1.1 
Dicalcium phosphate 1.4 
Fat3 8.0 
1 % in diet, wt:wt 
2Vitamin/mineral premix mix: vitamin A, 30,800 IU; Vitamin D3, 9,250 IU; vitamin E, 
153.9 IU; vitamin B12, 0.154 mg; riboflavin, 46.2 mg; niacin, 185 mg; pantothenic acid, 84 mg; 
menadione sodium bisulfite, 16.2 mg; folic acid, 12.3 mg; pyridoxine HCl, 46.2 mg; thiamine HCl, 
20.5 mg; biotin, 9.3 mg; choline, 2,944 mg; niacin, 185 mg  Cu, 55 mg; I, 7.3 mg; Fe, 366 mg; Mn, 
310 mg; Zn, 321 mg; K, 2.23 g; Mg, 1.09 g; Se, 0.48 mg 
3Supplied as either lard, canola oil, flaxseed oil or fish oil 
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Table S.2. Effects of dietary LA, CA, FL and FO on fatty acid profiles of phospholipids and total 
lipids in abdominal adipose tissue1 
 Phospholipids lipids (mole%) Neutral lipids (mole%) 
  LA CA FL FO LA CA FL FO 
C14:0 2.46 1.19 1.26 19.30 - - - 8.45 
C16:0  38.26 19.05 13.10 8.64 26.36 19.47 18.87 26.49 
C16:1n-7 - - - - 7.49 4.51 5.62 12.64 
C18:0 7.13 5.25 3.48 17.06 4.75 4.70 4.40 9.05 
C18:1n-9 - 41.30 18.27 - 39.63 48.05 28.00 33.75 
C18:2n-6 30.24 20.45 12.35 - 4.43 18.83 16.51 14.48 
C18:3n-3 2.15 4.27 21.12 3.97 - 4.44 26.59 - 
C20:4n-6 0.48 1.82 - 2.08 - - - - 
C20:5n-3 - - - 28.69 - - - 13.44 
C22:6n-3 - - - 16.68 - - - 8.18 
1LA= Lard; CA=Canola oil; FL=Flax; FO=Fish oil; N=1/diet 
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Figure S.1. Representative H&E-stained images of abdominal adipocytes; (A) Lard (LA), (B) 
Canola Oil (CA), (C) Flaxseed oil (FL), (D) Fish oil (FO); 20X magnification. 
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